<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81090</article-id><article-id pub-id-type="doi">10.7554/eLife.81090</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Single-nuclei characterization of pervasive transcriptional signatures across organs in response to COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author"><collab>The COVID Tissue Atlas Consortium<contrib-group><contrib><name><surname>Granados</surname><given-names>Alejandro</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Huang</surname><given-names>Franklin W</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Medicine and Liver Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Huang</surname><given-names>Guo N</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Physiology and Cardiovascular Research Institute, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Kattah</surname><given-names>Michael G</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Medicine and Liver Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Peng</surname><given-names>Tien</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Medicine and Liver Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Keller</surname><given-names>Andreas</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01jdpyv68</institution-id><institution>Department of Clinical Bioinformatics, Saarland University</institution></institution-wrap><addr-line><named-content content-type="city">Saarbrucken</named-content></addr-line><country>Germany</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Pisco</surname><given-names>Angela Oliveira</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Neff</surname><given-names>Norma</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Wang</surname><given-names>Bruce</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Medicine and Liver Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Song</surname><given-names>Hanbing</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Bucher</surname><given-names>Simon</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Medicine and Liver Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Chen</surname><given-names>Ann T</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Physiology and Cardiovascular Research Institute, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Agrawal</surname><given-names>Aditi</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Allen</surname><given-names>Nancy</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Medicine and Liver Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Hyams</surname><given-names>Benjamin</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Medicine and Liver Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Burhan</surname><given-names>Deviana</given-names></name></contrib><contrib><name><surname>Detweiler</surname><given-names>Angela</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Huynh</surname><given-names>Shelly</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Ludwig</surname><given-names>Nicole</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01jdpyv68</institution-id><institution>Department of Human Genetics, Saarland University</institution></institution-wrap><addr-line><named-content content-type="city">Homburg</named-content></addr-line><country>Germany</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Morri</surname><given-names>Maurizio</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Schultz-Schaeffer</surname><given-names>Walter</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01jdpyv68</institution-id><institution>Department of Neuropathology, Saarland University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Homburg</named-content></addr-line><country>Germany</country></aff><xref ref-type="fn" rid="con1"/></contrib><contrib><name><surname>Tan</surname><given-names>Michelle</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Weinstein</surname><given-names>Hannah NW</given-names></name></contrib><contrib><name><surname>Yan</surname><given-names>Rose</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Mekonen</surname><given-names>Honey</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Yan</surname><given-names>Rose Jia</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>McGeever</surname><given-names>Aaron</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Chen</surname><given-names>Xiaoxin</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01t8svj65</institution-id><institution>Department of Physiology and Cardiovascular Research Institute, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Galdos</surname><given-names>Francisco</given-names></name></contrib><contrib><name><surname>Mennillo</surname><given-names>Elvira</given-names></name></contrib><contrib><name><surname>Murti</surname><given-names>Abhishek</given-names></name></contrib><contrib><name><surname>Rao</surname><given-names>Poorvi</given-names></name></contrib><contrib><name><surname>Rusu</surname><given-names>Lulia</given-names></name></contrib><contrib><name><surname>Xie</surname><given-names>Jamie</given-names></name></contrib><contrib><name><surname>Liu</surname><given-names>Jonathan</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Huang</surname><given-names>Sharon S</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Tarashansky</surname><given-names>Alexander</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib><contrib><name><surname>Awayan</surname><given-names>Kyle</given-names></name><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></collab><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283153"><name><surname>Granados</surname><given-names>Alejandro A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6275-9800</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285664"><name><surname>Bucher</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267994"><name><surname>Song</surname><given-names>Hanbing</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-159674"><name><surname>Agrawal</surname><given-names>Aditi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285665"><name><surname>Chen</surname><given-names>Ann T</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109594"><name><surname>Peng</surname><given-names>Tien</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-163621"><name><surname>Neff</surname><given-names>Norma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174256"><name><surname>Pisco</surname><given-names>Angela Oliveira</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0142-2355</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198279"><name><surname>Huang</surname><given-names>Franklin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5447-0436</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-137390"><name><surname>Wang</surname><given-names>Bruce</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3486-5494</contrib-id><email>bruce.wang@ucsf.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00knt4f32</institution-id><institution>Chan-Zuckerberg Biohub</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Division of Gastroenterology, Department of Medicine, University of California, San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California San Francisco</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v76x132</institution-id><institution>Yale University</institution></institution-wrap><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Eyras</surname><given-names>Eduardo</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/019wvm592</institution-id><institution>Australian National University</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Walczak</surname><given-names>Aleksandra M</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02feahw73</institution-id><institution>CNRS</institution></institution-wrap><country>France</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>13</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e81090</elocation-id><history><date date-type="received" iso-8601-date="2022-06-15"><day>15</day><month>06</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-07-16"><day>16</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-05-31"><day>31</day><month>05</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.05.31.493925"/></event></pub-history><permissions><copyright-statement>© 2023, The COVID Tissue Atlas Consortium et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The COVID Tissue Atlas Consortium et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81090-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-81090-figures-v1.pdf"/><abstract><sec id="abs1"><title>Background:</title><p>Infection by coronavirus SARS-CoV2 is a severe and often deadly disease that has implications for the respiratory system and multiple organs across the human body. While the effects in the lung have been extensively studied, less is known about the impact COVID-19 has across other organs.</p></sec><sec id="abs2"><title>Methods:</title><p>Here, we contribute a single-nuclei RNA-sequencing atlas comprising six human organs across 20 autopsies where we analyzed the transcriptional changes due to COVID-19 in multiple cell types. The integration of data from multiple organs enabled the identification of systemic transcriptional changes.</p></sec><sec id="abs3"><title>Results:</title><p>Computational cross-organ analysis for endothelial cells and macrophages identified systemic transcriptional changes in these cell types in COVID-19 samples. In addition, analysis of gene modules showed enrichment of specific signaling pathways across multiple organs in COVID-19 autopsies.</p></sec><sec id="abs4"><title>Conclusions:</title><p>Altogether, the COVID Tissue Atlas enables the investigation of both cell type-specific and cross-organ transcriptional responses to COVID-19, providing insights into the molecular networks affected by the disease and highlighting novel potential targets for therapies and drug development.</p></sec><sec id="abs5"><title>Funding:</title><p>The Chan-Zuckerberg Initiative, The Chan-Zuckerberg Biohub.</p></sec></abstract><kwd-group kwd-group-type="author-keywords"><kwd>COVID</kwd><kwd>cell atlas</kwd><kwd>transcriptomics</kwd><kwd>RNA-seq</kwd><kwd>single-cell</kwd><kwd>transcriptional regulation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100014989</institution-id><institution>Chan Zuckerberg Initiative</institution></institution-wrap></funding-source><award-id>Covid Tissue Atlas</award-id><principal-award-recipient><name><surname>Granados</surname><given-names>Alejandro A</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL155622</award-id><principal-award-recipient><name><surname>Peng</surname><given-names>Tien</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL142552</award-id><principal-award-recipient><name><surname>Peng</surname><given-names>Tien</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A conserved transcriptional signature in macrophages and endothelial cells occurs in multiple organs in response to COVID-19 and suggests potential molecular interactions between the two cell types.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>COVID-19 (coronavirus disease 2019) is the most devastating infectious disease in recent history. The pandemic has impacted all parts of the globe and resulted in nearly 500 million infections and over 6,000,000 deaths (<xref ref-type="bibr" rid="bib7">Dong et al., 2020</xref>). Approximately 14% of infected unvaccinated individuals develop a severe clinical disease that requires hospitalization (<xref ref-type="bibr" rid="bib54">Wu and McGoogan, 2020</xref>). While the primary organ affected by severe COVID-19 is the lung, many other organs, including the heart, liver, and kidney, are also affected (<xref ref-type="bibr" rid="bib34">Mokhtari et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Xie et al., 2022</xref>; <xref ref-type="bibr" rid="bib51">Wang et al., 2021</xref>). In addition, long-COVID has become an important and common sequela in those who recover from infection. Long-COVID often affects multiple organs and is more common in patients with a severe initial infection (<xref ref-type="bibr" rid="bib48">Taquet et al., 2021</xref>).</p><p>The systemic effects of severe COVID-19 are largely mediated through the immune response to SARS-CoV-2 infection and subsequent inflammatory response. Viral infection stimulates macrophages to overproduce pro-inflammatory cytokines, including IL-6, leading to the ‘cytokine storm’ that results in systemic inflammatory response syndrome (<xref ref-type="bibr" rid="bib19">Hu et al., 2021</xref>). This heightened inflammatory state affects multiple organs, partly through effects on endothelial cells, which can be directly injured in response to pro-inflammatory cytokines and produce a procoagulant state leading to thrombosis (<xref ref-type="bibr" rid="bib10">Fard et al., 2021</xref>). Improved understanding of the cellular and molecular mechanisms that drive severe COVID-19 and lead to damage in specific organs, as well as the development of long-COVID, requires a multi-organ approach.</p><p>We have previously shown that multi-organ, single-cell transcriptome-based approaches can yield significant insights into organ biology and cross-organ signaling (<xref ref-type="bibr" rid="bib46">Tabula Muris Consortium et al., 2018</xref>; <xref ref-type="bibr" rid="bib22">Jones et al., 2022</xref>). In addition, several other studies have recently applied a single cell-based approach to autopsy samples from patients with severe COVID-19. These studies have yielded significant insights into how severe COVID-19 affects the lung (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Melms et al., 2021</xref>) and the brain (<xref ref-type="bibr" rid="bib60">Yang et al., 2021</xref>), but have not described in detail the systemic and cross-organ effects of severe COVID-19.</p><p>Here, we report a COVID-19 single-nuclei RNA-sequencing (snRNA-seq) atlas comprising six organs and approximately 86,000 cells. We showed that transcriptional changes in severe COVID-19 infections were not restricted to the lung, the most severely affected organ upon SARS-CoV-2 infection, but to multiple organs, such as the liver and heart. In addition, we found significant changes in the transcriptional profiles of multiple cell types and identified a subset of recurrent molecular pathways commonly up-regulated in multiple cell types across organs. The COVID Tissue Atlas (CTA) represents a comprehensive resource to investigate the transcriptional changes resulting from COVID-19 in different tissues. Moreover, the scope of the CTA dataset enabled us to identify systemic transcriptional signatures that we would have missed by focusing on an individual organ. We anticipate our analysis and the CTA to be of significant value for future research, including identifying molecular targets for drug development and therapeutic applications.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Sample collection</title><p>Organs from post-mortem control individuals and patients with COVID-19 were obtained at the time of autopsy from the University of California, San Francisco Medical Center, and the Saarland University Hospital Institute for Neuropathology. In both institutions, autopsies are exempt from local Institutional Review Board and Committee on Human Research oversight. All autopsies performed have informed consent from legal next of kin for use of tissues for research purposes. <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> presents all group characteristics.</p></sec><sec id="s2-2"><title>Tissue processing</title><p>During the autopsy, tissue samples were stored in ice-cold Wisconsin solution for transportation, then immediately processed as follows: tissues were rinsed twice with ice-cold PBS, then wiped off. Next, tissues were pre-cut into 1–2 mm<sup>3</sup> cubes, flash-frozen in dry ice, and then stored at –80°C for single-nuclei extraction and total RNA extraction.</p></sec><sec id="s2-3"><title>COVID-19 testing</title><p>COVID-19 testing was performed on patients according to the testing procedure of host hospitals. For sample testing, total RNA was extracted using a hybrid TRIzol (Life Technologies #15596026) and RNeasy Mini kit (QIAGEN #74104) protocol (<xref ref-type="bibr" rid="bib53">Wolock et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Rodriguez-Lanetty et al., 2006</xref>). RT-qPCR test for SARS-CoV2 mRNA detection was performed starting from 100 ng of total RNA using a one-Step RT-qPCR enzyme mix (QuantaBio, 94134-500), with primers and probes specific for the SARS-CoV-2 Nucleocapsid N1 and N2 genes, and for human gene ribonuclease PP30 which was used as an internal control (Integrated DNA Technologies, 10006713). The absolute number of transcripts was calculated using a standard curve generated with a positive control for the SARS-CoV2 Nucleocapsid sequence (Integrated DNA Technologies, 10006625).</p></sec><sec id="s2-4"><title>Nuclei dissociation</title><p>The protocol for nuclei isolation was performed in a BSL2+ biosafety cabinet for the lung and in a BSL2 biosafety cabinet for all other organs wearing personal protective equipment. We carried out all procedures on ice or at 4°C. Single nuclei were generated from around 50 mg of flash-frozen tissues using the Singulator machine (S2Genomics, Livermore, CA, USA), following the manufacturer’s recommendations. The extended protocol was used for the ileum and colon, and the regular protocol was used for all other organs. After isolation, nuclei preparations were cleaned as follows: nuclei were centrifuged at 500 × <italic>g</italic> for 5 min and resuspended in 2 ml of cold Storage Buffer (S2Genomics), then centrifuged again at 500 × <italic>g</italic> for 5 min, resuspended in 2 ml of Storage Buffer, and filtered through a 40 µm Flowmi Tip Strainer filter. After centrifugation, nuclei were resuspended in 50–500 µl of Storage Buffer supplemented with 1 U/µl of RNAse inhibitor (Sigma-Aldrich, cat: 3335402001) and counted using a LUNA-FL Dual Fluorescence Cell Counter (Logo Biosystems, Anyang-si, South Korea).</p></sec><sec id="s2-5"><title>10x Genomics protocol</title><p>For droplet-based snRNA-seq, libraries were prepared using the Chromium Next GEM Single Cell 3ʹ v.3.1 according to the manufacturer’s protocol (10x Genomics), targeting 10,000 nuclei per sample after counting with a TC20 Automated Cell Counter (Bio-Rad). We performed 12 cycles for cDNA amplification for all of the samples. To generate the final dual or single indexed 10X libraries, 13 cycles were performed.</p></sec><sec id="s2-6"><title>Library pooling and quality control</title><p>After library preparation, individual libraries were quality checked on an Agilent 4200 Tapestation using D5000 screen tape. These libraries were pooled equal molar into a total of seven pools ranging from 4 to 15 nM final concentration and quality checked again on an Agilent 4200 Tapestation using a D5000 screen tape, followed by qPCR on a Bio-Rad CFX96 RT PCR thermal cycler using the KAPA library quantification kit (# KK4923).</p></sec><sec id="s2-7"><title>Sequencing</title><p>Individual pools of 10x 3’ gene expression libraries were sequenced on Illumina’s Nextseq 2000 P3, Novaseq S2 and/or NovaSeq S4 flow cells with a targeted sequencing read depth of 20,000 reads per cell. Sequencing parameters were as follows: (1) for dual indexed libraries: Read 1=28 cycles, Index 1=10 cycles, Index 2=10 cycles, Read 2=90 cycles; (2) for single indexed libraries: Read 1=28 cycles, Index 1=8 cycles, Index 2=0 cycles, Read 2=91 cycles.</p></sec><sec id="s2-8"><title>Alignment</title><p>Sequences were de-multiplexed using bcl2fastq version 2.20.0.4.22. Reads were aligned to an extended Gencode Reference 30 (GRCh38) genome containing SARS-CoV2 genes (kindly provided by Aviv Regev and Carly Ziegler) using CellRanger version 5.0.1, available from 10x Genomics, with default parameters.</p></sec><sec id="s2-9"><title>snRNA-seq quality control</title><p>The count matrices generated by CellRanger were pre-processed by removing contamination of ambient RNA. We noticed high levels of contamination in single-nuclei data, which has been reported before (<xref ref-type="bibr" rid="bib59">Yang et al., 2020</xref>), and applied Cellbender version 0.1 (<xref ref-type="bibr" rid="bib12">Fleming et al., 2019</xref>) to generate decontaminated count matrices (FDR = 0.01 and default parameters). For quality control, pre-processing, and clustering, we used Scanpy (<xref ref-type="bibr" rid="bib52">Wolf et al., 2018</xref>). We applied quality control filters directly on the count matrices generated by Cellbender. The minimum number of counts per cell we applied as a cut-off varied depending on the sample and ranged between 300 and 800 counts per cell. We observed high mitochondrial content in some of the samples and filtered out cells that exceeded the cut-off threshold (10–20% depending on the sample). We also applied Scrublet for automated identification of potential doublets (<xref ref-type="bibr" rid="bib53">Wolock et al., 2019</xref>).</p></sec><sec id="s2-10"><title>Data clustering</title><p>For each organ, we first integrated the samples from different donors into a harmonized UMAP embedding using scVI (<xref ref-type="bibr" rid="bib28">Lopez et al., 2018</xref>) release 0.11.0. For training the scVI’s variational autoencoder neural network, we used default parameters except for <italic>n_latent = 64</italic> and <italic>n_layers = 2</italic>. We allowed each gene to have its own variance parameter by setting <italic>dispersion=&quot;gene&quot;</italic>. We then used the UMAP algorithm to visualize the resulting embedding in two dimensions. All UMAPs for each organ shown in the manuscript were generated in the same way. The UMAPs generated using scVI’s latent space showed minimal batch effect and allowed for the identification of cell populations based on known markers for each organ. For each organ, we first verified that individual clusters expressed known gene markers for the expected cell types. Some clusters, however, co-expressed multiple mutually exclusive markers, an indication of ambient RNA contamination, so we labeled these cells as doublets. Clusters that either expressed gene markers for multiple cell types (doublets) or did not express any markers for the cell types expected in the organ (unidentifiable cells) were systematically removed from the dataset. Finally, for each organ, we generated h5ad files with the cell-type annotations and the harmonized UMAP.</p></sec><sec id="s2-11"><title>Cell-type annotation</title><p>We used the batch-corrected UMAPs for cell-type annotation. In brief, tissue experts at either UCSF or Stanford (from research labs focused on specific human tissues) analyzed the expression of cell type-specific markers and assigned identities to the clusters. Confident annotations for some clusters, however, were not possible due to high levels of RNA contamination or low expression of marker genes. We therefore only considered clusters for which a cell-type identity was clearly defined. The second round of quality control was applied based on feedback from tissue experts and their annotations. We increased the cut-off values for mitochondrial genes and filtered out putative doublets (cells co-expressing gene markers for mutually exclusive cell types). After the second round of review with the tissue experts, we finalized the cell-type annotations for all organs and used them for all downstream analyses. We use the cell-type label annotations as ground truth for differential expression (DE) analysis, pathway enrichment, and ligand-receptor enrichment analysis (see Signaling interactions between cell types).</p></sec><sec id="s2-12"><title>Integration with external datasets</title><p>To annotate cell types in the kidney, we integrated our COVID-19 samples with a single-nuclei atlas of the kidney (<xref ref-type="bibr" rid="bib36">Muto et al., 2021</xref>). We applied scANVI (<xref ref-type="bibr" rid="bib58">Xu et al., 2021</xref>) for integration and label transfer. We confirmed that cell types from COVID-19 donors integrated well with the kidney atlas by inspection of cell type-specific markers (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C-E</xref>). We used the integrated kidney object to compute DE genes and gene pathway enrichment. Additionally, to increase the statistical significance of the identified DE genes, we integrated the COVID-19 and healthy lung single-nuclei samples with the lung data from the Tabula Sapiens dataset (<xref ref-type="bibr" rid="bib4">Consortium and Quake, 2021</xref>). This integration allowed us to increase the number of healthy cells in endothelial cells and macrophages for which we had not enough large populations in our healthy single-nuclei samples. We used scVI to integrate samples from the CTA and Tabula Sapiens and verified that cell types independently identified on each dataset clustered together in the harmonized embedding.</p><p>For the sub-clustering and analysis of lung epithelial cells, we independently integrated the CTA lung samples with the COVID-19 lung atlas published by the Broad Institute (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>) and with the lung dataset (<xref ref-type="bibr" rid="bib24">Kathiriya et al., 2022</xref>). For each data source, we considered only epithelial cells (basal, AT1, and AT2) and performed integration using Seurat 3 (<xref ref-type="bibr" rid="bib45">Stuart et al., 2019</xref>) (correcting batch effect by donor). We kept the original annotations from each dataset to perform comparisons. We set the default assay parameter to ‘RNA’ within the integrated dataset to compute the top 10 DE genes. To investigate the transcriptomic differences and similarities between (<xref ref-type="bibr" rid="bib24">Kathiriya et al., 2022</xref>) and the CTA dataset, we generated a hierarchical clustering heatmap by downsampling the datasets to 500 cells per population, using the top 20 genes in the signature gene sets developed in the control dataset. Heatmaps were generated using the R package <italic>pheatmap</italic> v1.0.12 with the clustering algorithm set to <italic>ward.D2</italic>.</p></sec><sec id="s2-13"><title>Differential gene expression</title><p>To identify DE genes between healthy and COVID-19 samples, we used a negative-binomial model using the <italic>zlm</italic> method as implemented by the MAST R package v1.20 (<xref ref-type="bibr" rid="bib11">Finak et al., 2015</xref>). Following standard practices in single-cell DE, we corrected for the number of detected genes as a potential confounding variable (<xref ref-type="bibr" rid="bib11">Finak et al., 2015</xref>). Finally, to correct the p-values for multiple testing, we applied Bonferroni correction and defined significant DE using an adjusted p-value cut-off of 0.05 and a minimum absolute log2 fold-change (log2-FC) of 1.</p></sec><sec id="s2-14"><title>Gene set enrichment analysis</title><p>To identify gene sets enriched in COVID-19 donors, we selected the top DE genes for each cell type (COVID-19 vs healthy) and used them as input for pathfindR (<xref ref-type="bibr" rid="bib49">Ulgen et al., 2019</xref>), a gene set enrichment algorithm that includes the fold-change along with potential interactions using a protein-protein interaction network. For selecting significant DE genes, we applied a threshold of log2-FC&gt;<italic>abs</italic>(1) and adjusted p-value &lt;0.001.</p><p>We used four different pathway databases as references for our analysis to be comprehensive, KEGG, Reactome, GO, and BioCarta. We then manually curated the enriched pathways, discussed them with tissue experts, and cross-validated them with existing literature to identify the signatures enriched in COVID-19 donors for each cell type and organ. We only considered enriched pathways with a p-value &lt;0.001.</p></sec><sec id="s2-15"><title>Coordination in transcriptional responses</title><p>To identify transcriptional coordination in COVID-19 samples, we developed a custom analysis method to quantify shared responses across organs. First, we examined the set of genes that appear DE (adjusted p-value &lt;0.001 and log2-FC &gt;<italic>abs</italic>(1)) in at least two-thirds of the organs. Some cell types appear in all organs, whereas some only appear in two or three. We, therefore, applied the coordination analysis only for cell types that appear in at least three organs (macrophages, fibroblasts, and endothelial cells).</p><p>We calculated a custom coordination score for each cell type, which was defined as follows. For a pair of organs, we took the set of shared DE genes common to both organs and computed the sign of change for each gene in each organ (i.e., positive/negative for up/down-regulation, respectively). For genes with the same sign in both organs, we assigned a value of 1; genes with opposing signs were assigned a value of 0. The coordination score for the pair of organs was then defined as the average value across shared DE genes (i.e., the sum of values divided by the number of genes). Thus, a coordination score of 1 indicates that all shared DE genes are jointly up- or down-regulated (i.e., perfect coordination). In contrast, a score of 0 indicates that they are oppositely up- or down-regulated (i.e., perfect anti-coordination). For each cell type and for each pair of organs, we thus computed the coordination score.</p><p>As a negative control, we repeated this analysis with a computationally shuffled dataset. Here, for each pair of organs for a particular cell type, we held the log2-FC values per gene in one organ fixed and randomly shuffled the log2-FC values per gene in the second organ. We reasoned that this shuffled dataset should possess near-zero coordination (i.e., a score of 0.5), with some small random deviation due to the finite size of the shared gene list. We generated N=1000 computationally shuffled datasets for each pair of organs and calculated the resulting coordination scores for each instance, producing a distribution of coordination scores as a negative control. We then averaged the results and retained the mean and standard error, to be compared with the coordination scores from the actual data. We then used the shared responses as input for pathway enrichment (see above), considering only the cell types that showed significant coordination compared to the random control (macrophages and endothelial cells).</p></sec><sec id="s2-16"><title>Signaling interactions between cell types</title><p>We applied CellPhoneDB (<xref ref-type="bibr" rid="bib8">Efremova et al., 2020</xref>) and identified significant pairs of ligands and receptors between macrophages and endothelial cells in COVID-19 tissues (adjusted p-value &lt;0.05). We first identified the significant ligand-receptor interactions in healthy and COVID-19 samples independently and considered only those that were enriched in COVID-19 but not in healthy samples.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><sec id="s3-1"><title>The CTA</title><p>We collected data from 20 different autopsies (17 males, 3 females) with an age range between 40 and 89 years (median age = 68 years), of which 15 tested positive for COVID-19 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The average time at which samples were collected was 63 hr post-mortem. Ethnicities were distributed as Hispanic (n=5), African American (n=2), Asian (n=1), and White (n=12). For COVID-19-positive autopsies, the average positive test time before death was 20 days; however, not all donors died due to COVID-19 complications (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We optimized single-nuclei RNA extraction and sequencing from frozen tissue for Biosafety Level 2 work. All samples were sequenced at the Chan Zuckerberg Biohub using 10x Genomics protocols. After quality control, 85,376 cells (60,946 cells from COVID-19 samples and 24,430 cells from healthy donors) were deemed high quality and used to form the CTA (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). snRNA-seq is prone to high levels of ambient RNA contamination, which we corrected by applying an established correction algorithm (<xref ref-type="bibr" rid="bib12">Fleming et al., 2019</xref>) along with filtering of doublets (Methods). The total numbers of single cells for each organ were as follows: heart (6092 healthy; 13,999 COVID-19), lung (9684 healthy; 11,790 COVID-19), liver (6768 healthy; 8889 COVID-19), prostate (1886 healthy; 8986 COVID-19), kidney (4060 COVID-19), and testis (13,222 COVID-19) (<xref ref-type="fig" rid="fig1">Figure 1D and E</xref>). Additionally, small intestine, colon, and uninfected control kidney specimens were processed but did not yield sufficient high-quality nuclei for inclusion. We were not able to collect uninfected testis tissue.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>A human single-cell atlas enables the identification of systemic responses to COVID-19.</title><p>(<bold>A</bold>) Tissue samples were collected from different organs and frozen, then dissociated into single nuclei. Libraries for single-nuclei RNA-sequencing (snRNA-seq) were prepared using 10x Genomics Chromium Next GEM Single Cell 3ʹ v.3.1kit, followed by sequencing on various Illumina platforms. After quality control and clustering, cell types for each organ were annotated by experts using literature gene markers. Differential gene expression and pathway enrichment analysis were performed between COVID-19 and healthy samples for all cell types. Finally, global transcriptional signatures were identified via a cross-organ analysis of differential expression. (<bold>B</bold>) The COVID tissue atlas comprises approximately 85,000 cells from six different organs. (<bold>C</bold>) Cells in the COVID tissue atlas cluster by cell identity rather than disease status. (<bold>D</bold>) Number of cells per donor grouped by the organ of origin. (<bold>E</bold>) Number of cells per organ grouped by COVID-19 status.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Clustering, batch correction, and annotation of single-nuclei samples.</title><p>(<bold>A</bold>) UMAP visualization of the liver data. Single cells are colored by their cell-type annotation (<bold>B</bold>) UMAP visualization of the heart data. Single cells are colored by their cell-type annotation. (<bold>C, D</bold>) UMAP visualizations of the liver (<bold>C</bold>) and heart (<bold>D</bold>) datasets. Single cells are colored by their corresponding donor (donorID shows the healthy and COVID-19 status of each donor). (<bold>E, F</bold>) Average gene expression of known cell-type markers for different cell types in the liver (<bold>E</bold>) and heart (<bold>F</bold>). The fraction of cells expressing the gene is represented by the size of the circles.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Clustering and annotation of additional organs.</title><p>(<bold>A</bold>) Relative sizes of the different cell populations identified in the prostate. The numbers of cells are normalized to add up to 100% for COVID-19 and healthy cells independently. (<bold>B</bold>) UMAP visualization of the prostate data. Single cells are colored by their cell-type annotation. (<bold>C</bold>) UMAP visualization of the kidney COVID Tissue Atlas (CTA) data after integration with a kidney single-nuclei atlas from healthy donors (<xref ref-type="bibr" rid="bib36">Muto et al., 2021</xref>). Cells from CTA samples were annotated by transferring labels from <xref ref-type="bibr" rid="bib36">Muto et al., 2021</xref>, using scanVI (<xref ref-type="bibr" rid="bib58">Xu et al., 2021</xref>). (<bold>D</bold>) UMAP of the integrated kidney dataset shown in (C), colored by dataset source (CTA kidney samples only contained cells from COVID-19-positive donors).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Comparison between whole-cell and single-nuclei RNA-seq.</title><p>(<bold>A</bold>) Distribution of total RNA counts per cell from whole-cell sequencing of two different liver samples <ext-link ext-link-type="uri" xlink:href="https://paperpile.com/c/jCkdQf/7r7m">(Tabula Sapiens Consortium* et al</ext-link><ext-link ext-link-type="uri" xlink:href="https://paperpile.com/c/jCkdQf/7r7m">. 2022).</ext-link> (<bold>B</bold>) Distribution of the total number of detected genes per cell from whole-cell sequencing of two different liver samples <ext-link ext-link-type="uri" xlink:href="https://paperpile.com/c/jCkdQf/7r7m">(Tabula Sapiens Consortium* et al</ext-link><ext-link ext-link-type="uri" xlink:href="https://paperpile.com/c/jCkdQf/7r7m">. 2022)</ext-link> (<bold>C</bold>) Number of total RNA counts for the same two liver samples sequenced from single nuclei instead of whole cell. (<bold>D</bold>) Same as (B) for the single-nuclei samples.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Detection of viral mRNA and expression of COVID-19 associated genes.</title><p>(<bold>A</bold>) Average copy number of SARS-CoV2 mRNA (log) measured by RT-qPCR for all samples. (<bold>B</bold>) Average gene expression of known COVID-19 associated genes in the lung. The fraction of cells expressing the gene is represented by the size of the circles. (<bold>C</bold>) Average gene expression of known COVID-19 associated genes in the other organs. The fraction of cells expressing the gene is represented by the size of the circles.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig1-figsupp4-v1.tif"/></fig></fig-group><p>We applied dimensionality reduction (PCA) and Leiden clustering for each organ while correcting batch effects across donors using scVI (<xref ref-type="bibr" rid="bib28">Lopez et al., 2018</xref>). Finally, we visualized the resulting clustering using UMAP (<xref ref-type="bibr" rid="bib30">McInnes et al., 2018</xref>). For each organ, we identified cell populations using the batch-corrected UMAP embedding by tissue experts based on the expression of known gene markers (Methods). We identified most major cell types in each organ. We verified that clusters with the same cell identity included healthy and COVID-19 cells, indicating that batch effects were removed (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref> and <xref ref-type="fig" rid="fig1s2">2</xref>). Additionally, we verified that our single-nuclei data was statistically comparable to whole-cell sequencing regarding the number of UMIs and detected genes (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>).</p><p>Measurements of SARS-CoV-2 mRNA by RT-qPCR showed high to moderate expression in the lung samples from COVID-19 donors (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>). While some of the COVID-19 associated genes such as ACE2, TMPRSS2, and NRP1 were expressed in multiple organs (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4C</xref>), we did not detect significant viral mRNA load by RT-qPCR in the other organs processed (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>). The low detection rate of viral mRNA could be attributed to the prolonged periods between initial infection and sample collection for some donors (<xref ref-type="bibr" rid="bib5">Deinhardt-Emmer et al., 2021</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Due to the balanced representation of healthy and COVID-19 donors for lung, heart, and liver, we decided to focus our downstream analysis on understanding the transcriptional responses of cell types in these organs. For the kidney, we integrated our data with a healthy single-nuclei atlas reference (<xref ref-type="bibr" rid="bib36">Muto et al., 2021</xref>) and made the integrated object available (Data Availability). The results for DE analysis between COVID-19 and healthy samples for lung, heart, liver, kidney, and prostate are available as part of the CTA data release (<xref ref-type="supplementary-material" rid="supp2 supp3">Supplementary files 2 and 3</xref>). Finally, our testis data, including only COVID-19 samples, is fully annotated and publicly available as part of the CTA release.</p></sec><sec id="s3-2"><title>Cell-type population changes in the COVID-19 lung</title><p>The CTA lung dataset comprised 21,474 cells, of which 11,790 were collected from COVID-19 autopsies. After quality control and clustering (Methods), we identified 10 distinct cell types, including primary epithelial and immune cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A, B</xref>). Several lung single-nuclei and single-cell efforts have been published throughout the COVID-19 pandemic (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Xu et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Hasan et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Melms et al., 2021</xref>). To assess the quality and scope of the CTA, we compared our data to the comprehensive lung atlas generated by the Broad Institute (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>). We applied anchor-based integration (<xref ref-type="bibr" rid="bib45">Stuart et al., 2019</xref>) to the lung samples from both datasets by including autopsies from the Broad atlas as additional donors in the CTA (Methods). After integration, the harmonized UMAP embedding showed that all major lung cell types integrated well across datasets (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), with cells from the CTA and the Broad atlas contributing to most clusters (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The alignment between datasets showed that the CTA captured the expected diversity of cell types in the COVID-19 lung and that the gene expression profiles were similar for the same cell types across datasets.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Cell type composition changes in the COVID-19 lung.</title><p>(<bold>A</bold>) Integration of the COVID Tissue Atlas (CTA) lung with the lung COVID atlas by the Broad Institute. A harmonized UMAP shows that cells from both datasets integrate by their corresponding cell-type annotation. (<bold>B</bold>) Integration of two lung COVID atlas colored by the dataset of origin. (<bold>C</bold>) Sub-clustering and UMAP projection of the CTA lung epithelial cells (AT1, AT2, and basal cells). (<bold>D</bold>) Relative cell composition in epithelial lung tissue from control and COVID-19 autopsies (CTA data only). (<bold>E</bold>) Integration of CTA epithelial cells and epithelial cells from <xref ref-type="bibr" rid="bib16">Habermann et al., 2020</xref> (AT1, AT2, basal cells, and transitional ABIs/AT2 populations). ABIs/transitional AT2 from <xref ref-type="bibr" rid="bib16">Habermann et al., 2020</xref>, are shown in red (right). (<bold>F</bold>) Heatmap of scaled gene expression of marker genes for three different reference cell populations (x-axis) compared to the CTA lung cell types (y-axis). (<bold>G</bold>) Joint embedding of CTA and <xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref> (AT1, AT2, basal, and pre-transitional cell state [PATS] cells). The PATS cells identified by <xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>, are shown in red in the joint UMAP (right).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cell-type composition of the COVID-19 lung.</title><p>(<bold>A</bold>) Relative sizes of the different cell populations identified in the lung. The numbers of cells are normalized to add up to 100% for COVID-19 cells and healthy cells independently. (<bold>B</bold>) UMAP visualization of the lung data. Single cells are colored by their cell type annotation. (<bold>C</bold>) Sankey diagram showing the distribution of individual cells across donors, COVID-19 status, and cell-type annotation of epithelial cells from the lung. (<bold>D</bold>) Expression of gene markers across the three populations of epithelial cells identified in the lung data.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig2-figsupp1-v1.tif"/></fig></fig-group><p>We next focused on the effects that COVID-19 has on the different lung cell populations. In particular, significant epithelial cell damage resulting from COVID-19 is manifested as loss of alveolar type 1 (AT1) and alveolar type 2 (AT2) cells (<xref ref-type="bibr" rid="bib31">Melms et al., 2021</xref>; <xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>). To investigate the changes in lung epithelial cells in COVID-19 autopsies in detail, we subset and re-clustered the AT1, AT2, and basal cells to obtain a new UMAP embedding (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). All three cell types included healthy and COVID-19 cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>) and expressed the corresponding canonical gene markers (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Consistent with previous studies (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Melms et al., 2021</xref>), we identified loss of AT1 and AT2 cells in COVID-19 lungs relative to healthy controls (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), along with a significant expansion of basal cells (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><p>COVID-19 is known to cause severe alveolar damage and loss of epithelial cells. During alveolar injury, AT2 cells are known to serve as progenitors to generate new epithelial cells. More recently, an additional cellular pathway has been identified where AT2-derived basaloid cells generate AT1 cells, termed alveolar basal intermediates. These cells were first identified in single-cell studies as KRT17+/KRT5- basaloid cells in human idiopathic pulmonary fibrosis (IPF) lungs (<xref ref-type="bibr" rid="bib16">Habermann et al., 2020</xref>) and independently shown by in vitro studies to arise from AT2 cells (<xref ref-type="bibr" rid="bib24">Kathiriya et al., 2022</xref>). To find if the increase in basal cells in COVID-19 lungs could be explained by trans-differentiation from AT2 cells, we integrated the CTA lung epithelial cells with an sc-RNA-seq dataset of lungs with IPF comprising two populations of transitional cells: KRT17+/KRT5- ABI cells, and transitional AT2 cells with a similar transcriptomic profile to AT1 cells (<xref ref-type="bibr" rid="bib16">Habermann et al., 2020</xref>). After applying anchor-based integration (Methods), the harmonized UMAP showed that epithelial cells from both datasets generally integrated well (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><p>Interestingly, while most of the transitional cells from <xref ref-type="bibr" rid="bib16">Habermann et al., 2020</xref>, mapped to the AT1 cluster, likely corresponding to transitional AT2s, a smaller fraction mapped to a specific cluster between the AT2 and basal cell populations from the CTA (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, right). To verify if this cluster from the CTA indeed corresponds to ABIs, we looked at genes up-regulated in ABIs (<xref ref-type="bibr" rid="bib24">Kathiriya et al., 2022</xref>). We found that the ABI gene expression profile was predominantly expressed within basal cells in CTA (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Thus, our data suggest that ABIs (<xref ref-type="bibr" rid="bib24">Kathiriya et al., 2022</xref>) are present in the COVID-19 lung, and their trans-differentiation from endogenous AT2s could account for the gain of abnormal basal cells in the alveoli, which are lost in COVID-19 lungs.</p><p>Alternatively, the Broad atlas identified a pre-AT1 transitional cell state (PATS) population in COVID-19 lungs (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>) that bears similarities to what was previously described as ABIs/transitional AT2s/aberrant basaloid cells from IPF lungs (<xref ref-type="bibr" rid="bib1">Adams et al., 2020</xref>; <xref ref-type="bibr" rid="bib16">Habermann et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Kathiriya et al., 2022</xref>). We jointly analyzed the lung epithelial cells from the CTA and the Broad atlas to determine if the PATS population was present in our data. We used anchor-based integration (<xref ref-type="bibr" rid="bib45">Stuart et al., 2019</xref>) and obtained a harmonized UMAP embedding which recapitulated the three populations across datasets (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). The PATS population mostly overlapped with the principal AT1 cluster (<xref ref-type="fig" rid="fig2">Figure 2G</xref>, right), but no specific cluster from the CTA mapped directly to the PATS cells. This analysis indicates that the PATS population (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>) is likely attributed to patient-specific cellular heterogeneity (or sequencing method differences) and, therefore, was not detected in the CTA donors. Together, our results contribute to our understanding of the multiple regenerative strategies involved in re-establishing alveolar epithelial homeostasis in response to COVID-19 (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>).</p></sec><sec id="s3-3"><title>Insulin signaling dysregulation in the liver</title><p>Across all six cell types identified in the liver (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), hepatocytes comprised around 60% of cells in the healthy samples and more than 80% in the COVID-19 samples (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). However, we observed an inverse trend for endothelial cells, where approximately 20% of the cells from healthy samples were annotated as endothelial as opposed to less than 10% in COVID-19 donors, which may reflect recently reported endotheliopathy in COVID-19 livers (<xref ref-type="bibr" rid="bib29">McConnell et al., 2021</xref>). COVID-19 livers also contained lower proportions of most immune cell populations than controls (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Transcriptional changes and dysregulation of cell signaling in the COVID-19 liver.</title><p>(<bold>A</bold>) UMAP plot showing all cells from liver samples (n=6 donors) colored by COVID-19 status. Cell-type annotations are indicated for each cluster. (<bold>B</bold>) Fraction of cells for each cell type grouped by COVID-19 status. (<bold>C</bold>) The number of differentially expressed (DE) genes found using MAST (<xref ref-type="bibr" rid="bib11">Finak et al., 2015</xref>) (negative-binomial model, correcting for the number of detected genes, p&lt;1e-6 and log2 fold change (log2-FC) &gt;2). (<bold>D</bold>) The top enriched signaling pathways found for each cell type based on the DE genes shown in (C). (<bold>E</bold>) Heatmap of log2-FC for the top DE genes. A few relevant genes are highlighted with a text legend.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Sequencing depth in healthy and COVID-19 samples.</title><p>(<bold>A</bold>) Total counts per cell (after quality control) in liver samples grouped by their COVID-19 status. A violin plot is shown for each donor. (<bold>B</bold>) Total counts per cell (after quality control) across all organs grouped by their COVID-19 status. For kidney and testis, only samples from COVID-19-positive donors were collected. Each violin plot shows the distribution of an organ after pooling cells from all donors together.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Endothelial subpopulations in the lung.</title><p>(a) Endothelial cells from the lung colored by disease status, (b) donor ID, and (c) Leiden cluster label. (d) Dot plot of cell-type score enrichment for different endothelial gene signatures. The score is calculated based on a list of known markers (<xref ref-type="bibr" rid="bib44">Schupp et al., 2021</xref>) and shown for each cluster in (C). Cluster 0 is labeled as NA as it did not score high for any of the reference gene signatures. (d) Bar plot showing the proportions of the identified endothelial sub-cell types in both the control and COVID-19 groups. (e) Absolute numbers of cells for the identified cell types in both the control and COVID-19 groups. (f) The biological processes up-regulated in the general capillary population. (g) The biological processes up-regulated in the aerocyte population.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Endothelial subpopulations in the heart.</title><p>(a) Endothelial cells from the heart colored by donor ID, (b) disease status, and (c) Leiden cluster label. (d) Dot plot of cell-type score enrichment for different endothelial gene signatures. The score is calculated based on a list of known markers and shown for each cluster in (C). Cluster 1 is labeled as NA as it did not score high for any of the reference cell types. (d) Bar plot showing proportions of the identified endothelial sub-cell types in both the control and COVID-19 groups. (e) Absolute numbers of cells for the identified cell types in both the control and COVID-19 groups.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig3-figsupp3-v1.tif"/></fig></fig-group><p>To identify DE genes for each cell type in the liver, we applied a negative-binomial model implemented in MAST (<xref ref-type="bibr" rid="bib11">Finak et al., 2015</xref>) that corrects for differences in sequencing depth across samples. Across all cell types, hepatocytes, endothelial cells, and macrophages showed the largest number of DE genes in COVID-19 donors (more than 200 up-regulated genes with an average log2-FC &gt;2 and adjusted-p &lt;1e-6; <xref ref-type="fig" rid="fig3">Figure 3C</xref>). In contrast, fibroblasts, intrahepatic cholangiocytes, and natural killer cells showed only a fraction of DE genes in comparison (fewer than 50 up-regulated genes; <xref ref-type="fig" rid="fig3">Figure 3C</xref>). Samples from COVID-19 livers generally comprised lower counts per cell (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>); while we corrected for this difference when computing DE genes (Methods), we decided to focus on COVID-19 over-expressed genes to minimize potential artifacts in down-regulation resulting from lower sequencing depth.</p><p>Next, we applied pathway enrichment using pathfindR, an algorithm that identifies significant sets of genes based on a reference pathway database and a protein-protein interaction network (<xref ref-type="bibr" rid="bib49">Ulgen et al., 2019</xref>). We identified dysregulated signaling pathways in COVID-19 livers using four different reference pathway databases: KEGG (<xref ref-type="bibr" rid="bib23">Kanehisa et al., 2016</xref>), BioCarta (<xref ref-type="bibr" rid="bib37">Nishimura, 2001</xref>), GO (<xref ref-type="bibr" rid="bib32">Mi et al., 2019</xref>), and Reactome (<xref ref-type="bibr" rid="bib15">Griss et al., 2020</xref>). We found known COVID-19-related gene sets in hepatocytes and macrophages (‘<italic>Coronavirus disease - COVID-19</italic>’ in the KEGG database), including TMPRSS2, EGFR, PLCG2, MAPK14, FOS, JUN, IFNAR1, C5AR1, CFB, C8G, MASP1, FGA, FGB, FGG in addition to multiple ribosomal-related transcripts, p&lt;1e-6 (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). The expression of known COVID-19 genes indicates general agreement between our data and previous studies (<xref ref-type="bibr" rid="bib17">Harrison et al., 2020</xref>).</p><p>Several pathways were enriched in multiple cell types in the liver across all four databases, including insulin, HIF-1, Notch, MAPK, and FoxO signaling (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). We found dysregulation in the insulin signaling pathway in hepatocytes, macrophages, and endothelial cells from COVID-19 livers (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>; p&lt;1e-6). Specifically, we observed up-regulation of genes involved in insulin response, including INSR, PIK3R1, PIK3CB, GSK3B, PPP1CB, PHKA2, PRKAR1A, SORBS1, CBL, CBLB, ACACA, HK1, PRKAG2, RPS6, RHEB, PTPN1 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Patients with type 2 diabetes have worse outcomes with severe COVID-19 infection (<xref ref-type="bibr" rid="bib55">Xie and Al-Aly, 2022</xref>), and clinical studies show aberrant glucose levels in SARS-CoV2 infected patients with type 2 diabetes (<xref ref-type="bibr" rid="bib39">Reiterer et al., 2021</xref>). Thus, our data suggest that dysregulated insulin signaling – especially in hepatocytes, which play a critical role in maintaining glucose homeostasis (<xref ref-type="bibr" rid="bib25">Klover and Mooney, 2004</xref>) – might explain why SARS-CoV2 infected patients with type 2 diabetes have uncontrolled glucose homeostasis and are comorbid (<xref ref-type="bibr" rid="bib33">Mishra and Dey, 2021</xref>) and why COVID-19 infection could lead to the development of type 2 diabetes (<xref ref-type="bibr" rid="bib2">Barrett et al., 2022</xref>).</p></sec><sec id="s3-4"><title>Signaling in the heart in response to COVID-19</title><p>COVID-19 can lead to cardiac involvement and injury via the following possible mechanisms: (1) indirect injury due to increased cytokines and immune inflammatory response, (2) direct invasion of cardiomyocytes by SARS-CoV-2, and (3) respiratory damage from the virus causing hypoxia leading to oxidative stress and injury to cardiomyocytes (<xref ref-type="bibr" rid="bib47">Tahir et al., 2020</xref>). To understand the transcriptional changes induced by COVID-19 in the heart, we analyzed differential gene expression across cell types and identified the critical signaling pathways dysregulated in response to COVID-19.</p><p>Heart samples yielded 20,091 cells after quality control (n=11 donors) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Across the eight cell types identified, the large majority of cells corresponded to endothelial cells (&gt;40% in COVID-19 samples, 13% in healthy samples), cardiomyocytes (25% in COVID-19 samples, 28% in healthy samples), and fibroblasts (15% in COVID-19 samples, 45% in healthy samples) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). To further explore the changes in endothelial cells, we independently re-clustered the endothelial cells from the lung and the heart and annotated sub-cell types based on known markers [<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2a, b, c</xref> (<xref ref-type="bibr" rid="bib27">Litviňuková et al., 2020</xref>)]. We identified four clusters of endothelial cells in the lung that we classified as vascular, capillary, and aerocytes, based on their expression profiles (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2d</xref>). We then compared the relative composition of endothelial sub-cell types in healthy and COVID-19 samples and noticed an increase in the relative composition of capillary and aerocyte sub-classes (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2f</xref>). Consistent with this, gene ontology (GO) analysis of the DE genes from capillary endothelial cells in the lungs showed that angiogenesis genes are significantly up-regulated (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2h</xref>). Additionally, following a similar analysis in the heart, we found an increase in capillary and arterial endothelial sub-cell types (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Therefore, the higher number of endothelial cells in COVID-19 tissues is correlated with an increasing population of capillary endothelial cells.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Transcriptional changes and dysregulation of cell signaling in the COVID-19 heart.</title><p>(<bold>A</bold>) UMAP plot showing all cells from heart samples (n=11 donors) colored by COVID-19 status. Cell-type annotations are indicated for each cluster. (<bold>B</bold>) Fraction of cells for each cell type grouped by COVID-19 status. (<bold>C</bold>) The number of differentially expressed genes found using MAST (<xref ref-type="bibr" rid="bib11">Finak et al., 2015</xref>) (negative-binomial model, correcting for the number of detected genes, p&lt;1e-6 and log2 fold change (log2-FC) &gt;2). (<bold>D</bold>) The top signaling pathways found for each cell type using the genes in (C). (<bold>E</bold>) Heatmap of log2-FC for the top differentially expressed genes. A few relevant genes are highlighted with a text legend.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig4-v1.tif"/></fig><p>We then found significant transcriptional changes in cardiomyocytes, endothelial cells, and macrophages based on the number of DE genes in COVID-19 samples (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Considering the top DE genes for each cell type, we then focused on understanding how COVID-19 affects heart cells in terms of gene regulatory pathways. We first confirmed that our results agreed with current gene sets associated with COVID-19 (KEGG: <italic>Coronavirus disease - COVID19</italic> pathway in fibroblasts and macrophages, p&lt;1e-5; Reactome: <italic>Influenza infection</italic> enriched in fibroblasts, p&lt;1e-5; <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). In addition, multiple genes and GO pathways related to protein translation and ribosome activity (RNA polymerase II cis-regulatory region sequence-specific DNA binding), along with signaling and transcription factor activity (intracellular signal transduction, transcription cis-regulatory region binding, transcription factor binding), were enriched in multiple COVID-19 heart cell types (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><p>Similar to the liver, we observed insulin pathway enrichment in cardiomyocytes from COVID-19 samples (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Heart failure is associated with generalized insulin resistance. Moreover, insulin-resistant states such as type 2 diabetes mellitus and obesity increase the risk of heart failure even after adjusting for traditional risk factors (<xref ref-type="bibr" rid="bib40">Riehle and Abel, 2016</xref>). In agreement with our data, other studies found that COVID-19 triggers insulin resistance in patients, causing chronic metabolic disorders that were non-existent before infection (<xref ref-type="bibr" rid="bib13">Govender et al., 2021</xref>). Additionally, we observed significant changes in Notch, Hippo, and MAPK signaling pathways in cardiomyocytes from COVID-19 samples (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Conversely, the BMP and TGFβ signaling pathways showed specific down-regulation in endothelial cells from COVID-19 hearts, including down-regulation of BMPR1A, BMPR1B, SMAD6, and BMP6 (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><p>Interestingly, Notch signaling has been proposed as a target to prevent SARS-CoV-2 infection and interfere with the progression of COVID-19 associated heart and lung disease (<xref ref-type="bibr" rid="bib41">Rizzo et al., 2020</xref>). Hippo signaling also appeared as one of the top signaling terms for cardiomyocytes (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Recent studies indicate that Hippo signaling is involved in the development of many diseases caused by viruses. Whether virus-induced diseases, specifically COVID-19, can be ameliorated by modulating the Hippo signaling pathway is worth pursuing (<xref ref-type="bibr" rid="bib50">Wang et al., 2019</xref>). Finally, TGFβ signaling is linked to the response of endothelial cells to inflammation in COVID-19 (<xref ref-type="bibr" rid="bib62">Yoshimatsu and Watabe, 2022</xref>). Together, these results build on previously reported evidence to show that multiple signaling pathways in the heart undergo both cell type-specific and systemic changes in response to COVID-19.</p></sec><sec id="s3-5"><title>Shared transcriptional responses across organs</title><p>The CTA provides a unique opportunity to identify systemic transcriptional responses across organs. As an indication of a systemic response to COVID-19, we found enrichment of the same signaling pathways in multiple cell types and across organs, including HIF-1, insulin, and Notch signaling (<xref ref-type="fig" rid="fig3">Figures 3D</xref> and <xref ref-type="fig" rid="fig4">4D</xref>). Therefore, we decided to quantify the cross-organ transcriptional changes in COVID-19 autopsies by finding overlapping sets of DE genes and signaling pathways across organs.</p><p>In macrophages, we found a significant overlap in DE genes across organs compared to random sampling expectations (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Specifically, we found a set of 89 DE genes in COVID-19 macrophages from all three organs, including PLCG2, HIF1A, ACTB, and JUND. There were also many overlapping DE genes in pairs of organs, with macrophages from the liver and lung showing the highest overlap with 124 shared DE genes (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). We performed the same analysis for endothelial cells and also found sets of overlapping DE genes, the highest overlap occurring between endothelial cells from the liver and lung (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> and <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>A shared transcriptional response in macrophages and endothelial cells across organs.</title><p>(<bold>A</bold>) Overlap of differentially expressed (DE) genes in COVID-19 macrophages across organs. The gray shaded area indicates the expected overlap for each organ combination (green circles) under a null hypothesis of random sampling (we computed the p-values against this null model). The white bars indicate the number of genes that showed DE in a single organ. The names of the top genes DE in all three organs are shown based on their log2-fold enrichment. (<bold>B</bold>) Scatter plot comparing the log2 fold change (log2-FC) for DE genes in COVID-19 macrophages from lung and heart. (<bold>C</bold>) Same as (B) but compares DE genes in COVID-19 macrophages from the liver and heart. (<bold>D</bold>) log2-FC for COVID-19 endothelial cells from the liver and heart. (<bold>E</bold>) log2-FC for COVID-19 stromal cells from the liver and kidney. (<bold>F</bold>) A fully coordinated transcriptional signature would imply that all genes lie in the bottom-left and top-right quadrants (red squares). We define the coordination score as the number of DE genes that show the same direction (up-up, down-down) for the two organs, divided by the number of shared DE genes (<bold>A</bold>). Gray bars show the score expectation when sampling DE genes randomly from each organ. (<bold>G</bold>) Coordination scores for different cell types across all pairs of organs. The dotted line indicates a significance threshold of z-score &gt;5 standard deviations compared to the expectation by chance. (<bold>H</bold>) Scatterplot of log2-FC between control and COVID-19 for macrophages from three different organs. Each dot represents a gene; the x-axis shows the log2-FC found using data from the COVID Tissue Atlas (CTA), while the y-axis shows the corresponding log2-FC found using the Broad COVID-19 atlas. The same methods and significance thresholds were applied to both datasets. The scatterplot shows the genes that showed significant differences in both datasets. A few examples with coordinated upregulation across all three organs in both datasets are indicated by name.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Overlapping differentially expressed (DE) genes in endothelial cells across organs.</title><p>(<bold>A</bold>) Overlap of DE genes in COVID-19 endothelial cells across organs. The gray shaded area indicates the expected overlap for each organ combination (green circles) under a null hypothesis of random sampling (we computed the p-values against this null model). The white bars indicate the number of genes that showed DE in a single organ. The names of the top DE genes in all three organs are shown based on their log2-fold enrichment. (<bold>B</bold>) Scatterplot of log2 fold change (log2-FC) between control and COVID-19 for endothelial cells from three different organs. Each dot represents a gene; the x-axis shows the log2-FC found using data from the COVID Tissue Atlas (CTA), while the y-axis shows the corresponding log2-FC found using the Broad COVID-19 atlas. The same methods and significance thresholds were applied to both datasets. The scatterplot includes the genes that showed significant differences in both datasets. The Pearson correlation coefficient is shown for each organ.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To further analyze these data, we defined the shared transcriptional response (STR) for a cell type as the set of genes that show DE in at least three organs from COVID-19 donors (p&lt;1e-4 and log2-FC &gt;1). We restricted the analysis to macrophages, endothelial cells, and stromal cells, which appear in multiple organs, and calculated the correlation between the log-FC values of all genes in the STR across pairs of organs (<xref ref-type="fig" rid="fig5">Figure 5B–E</xref>). Generally, we saw high correlation coefficients, indicating coordination in the COVID-19 induced STR across organs. For example, among the genes with the highest log-FC across organs, we found HIF1A (in macrophages from liver, lung, and heart; <xref ref-type="fig" rid="fig5">Figure 5B–C</xref>), JUND (in macrophages from liver and heart; <xref ref-type="fig" rid="fig5">Figure 5C</xref>), and PLCG2 (in endothelial cells from liver and heart; <xref ref-type="fig" rid="fig5">Figure 5D</xref>).</p><p>To identify the cell types with high coordination in their STR across organs, we defined a coordination score by considering pairs of organs and the fraction of genes in the STR that showed the same direction in DE (upregulated in both or down-regulated in both; <xref ref-type="fig" rid="fig5">Figure 5F</xref>). Finally, we generated a null distribution for the expected coordination by shuffling the log-FC across genes (<xref ref-type="fig" rid="fig5">Figure 5F</xref>; Methods) and computed a z-score between the null distribution and the observed coordination for each cell type and pair of organs (<xref ref-type="fig" rid="fig5">Figure 5G</xref>).</p><p>The STR of endothelial cells from COVID-19 samples showed the highest coordination across multiple pairs of organs (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). These results are consistent with previous studies focused on the effect of COVID-19 on endothelial tissues (<xref ref-type="bibr" rid="bib43">Ruhl et al., 2021</xref>; <xref ref-type="bibr" rid="bib20">Huertas et al., 2020</xref>). We also found significant coordination in macrophages across the liver, lung, and heart (z-score &gt;5; <xref ref-type="fig" rid="fig5">Figure 5G</xref>). Macrophages from the lung showed lower coordination scores compared to the heart and liver, an indication of lung-specific transcriptional regulation (<xref ref-type="fig" rid="fig5">Figure 5G</xref> and <xref ref-type="fig" rid="fig5">Figure 5B</xref> off-diagonal quadrants). In contrast, the STR of fibroblasts and stromal cells showed no significant coordination compared to the randomized control, possibly due to the low number of overlapping DE genes (<xref ref-type="fig" rid="fig5">Figure 5G</xref> and <xref ref-type="fig" rid="fig3">Figures 3C</xref> and <xref ref-type="fig" rid="fig4">4C</xref>).</p><p>To further validate the SRT across multiple organs, we applied our analysis to the Broad COVID-19 atlas (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>). The Broad atlas includes lung, liver, and heart samples from COVID-19 autopsies. We first computed DE and log2-fold enrichment between controls and COVID-19 samples for macrophages and endothelial cells on each organ independently. As described above, we found the coordinated DE as the overlapping sets of genes that showed significant differences in all three organs. From 125 significantly expressed genes found in the SRT response of macrophages in the CTA, 65 also appeared in the Broad atlas, representing a 52% overlap across datasets (equivalently, we found a 31% overlap for the SRT in endothelial cells – <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref>). Finally, we compared the log2-FC magnitudes for the overlapping genes across datasets (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). The strength of the correlation between log2-FC across independent datasets indicates that the differences we found in the CTA and the coordination of transcriptional responses in multiple organs are robust and likely generalizable in COVID-19. Together, these results indicate that COVID-19 infection induces coordinated transcriptional regulation in macrophages and endothelial cells across multiple organs.</p></sec><sec id="s3-6"><title>Systemic transcriptional responses in endothelial cells and macrophages</title><p>To investigate the relevance of the COVID-19 STR in macrophages and endothelial cells, we identified enriched pathways considering the genes that showed coordinated DE in at least three organs (diagonal quadrants in <xref ref-type="fig" rid="fig5">Figure 5B–E</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). We visualized the results as a matrix of pathways vs. organs, including the top pathway terms (p&lt;1e-3, fold enrichment &gt;3) that appeared in at least two organs for macrophages (<xref ref-type="fig" rid="fig6">Figure 6A</xref>) and endothelial cells (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Multiple signaling pathways were enriched in the STR of macrophages across organs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). The HIF-1 pathway showed high fold enrichment across all organs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), suggesting a pivotal role of macrophages in the systemic response to oxygen homeostasis in COVID-19. The Notch pathway was also enriched in macrophages from all three organs (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), confirming that Notch signaling has a crucial role in the systemic response to COVID-19 (<xref ref-type="bibr" rid="bib3">Breikaa and Lilly, 2021</xref>; <xref ref-type="bibr" rid="bib9">Farahani et al., 2022</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Identifying interactions between endothelial cells and macrophages.</title><p>(<bold>A</bold>) From the shared differentially expressed (DE) genes across organs, we identified the top enriched signaling pathways for COVID-19 macrophages across the lung, liver, and heart. The value in the heatmap is the log10 p-value for the gene pathway. Only pathways with fold enrichment &gt;3 and adjusted p-value &lt;1e-3 in at least two organs are shown. (<bold>B</bold>) Enriched pathways in the shared transcriptional response of endothelial cells across the lung, liver, and heart (using the same significance thresholds as (A)). (<bold>C–E</bold>) Enriched expression of ligand-receptor components in COVID-19 macrophages and endothelial cells in the lung (<bold>C</bold>), heart (<bold>D</bold>), and liver (<bold>E</bold>). The x-axis indicates the pair of cell types considered (EC endothelial cells, MA macrophages). The y-axis indicates all the enriched signaling interactions found, and the circles indicate the significance and magnitude of enrichment. We calculated enrichment using CellPhoneDB on the raw sequencing counts. Only ligand-receptor pairs with adjusted p-value &lt;1e-3 are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81090-fig6-v1.tif"/></fig><p>The STR consists of shared DE genes across multiple organs; however, the magnitude of the DE of a given gene, in terms of log-FC and p-value, can vary across organs (<xref ref-type="fig" rid="fig5">Figure 5B–E</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Therefore, when performing pathway analysis, some signaling pathways showed statistically significant enrichment only in subsets of tissues. For example, in macrophages, interleukin-4/13 showed significant enrichment only in the liver and heart and the adherens junction pathway only in the liver and the lung (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Similarly, a few gene pathways showed organ-specific enrichment (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>), indicating that genes in the SRT, while simultaneously DE across organs, might also modulate some cellular processes in organ-specific ways due to quantitative DE differences.</p><p>In the coordinated STR of endothelial cells, we found multiple enriched pathways, including Notch and Ephrin signaling in the lung, liver, and heart (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Specifically, several Notch-related genes were upregulated in COVID-19 samples for all three organs, including HDAC9, a selective regulator of Notch, FBXW7, a regulator of angiogenesis through Notch (<xref ref-type="bibr" rid="bib21">Izumi et al., 2012</xref>), and TBLR1, an indirect Notch regulator through degradation (<xref ref-type="bibr" rid="bib38">Perissi et al., 2008</xref>). Additionally, we found enrichment for VEGF signaling in liver and heart (p&lt;1e-3, and lung p&lt;1e-2; <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Interestingly, despite upregulation of the VEGF signaling pathway in multiple organs, some pathway genes showed organ-specific regulation. For example, AKT3 was enriched in the liver and lung, whereas PXN contributed to VEGF signaling enrichment only in the heart and lung (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). A recent study using measurements of growth factors and cytokines in serum identified VEGF-D as the most predictive indicator for the severity of COVID-19 (<xref ref-type="bibr" rid="bib26">Kong et al., 2020</xref>). Similarly, VEGF was proposed as a promising therapeutic target for suppressing inflammation during SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib61">Yin et al., 2020</xref>). Our results indicate that changes in VEGF signaling in COVID-19 donors are not necessarily organ-specific but rather part of a systemic response of endothelial cells and, therefore, of relevance for the development of treatments and as potential drug targets.</p></sec><sec id="s3-7"><title>Macrophage-endothelial signaling interactions in COVID-19 tissues</title><p>The enrichment of key cell-to-cell pathways such as Notch and Ephrin in the STR of endothelial cells and macrophages due to COVID-19 suggests that these two cell types may be signaling to each other. Therefore, we used CellPhoneDB (<xref ref-type="bibr" rid="bib8">Efremova et al., 2020</xref>) to investigate potential signaling interactions between these two cell types by finding over-represented expression ligand-receptor pairs in COVID-19 samples compared to healthy donors (Methods).</p><p>Multiple enriched ligand-receptor pairs were identified between macrophages and endothelial cells in all three organs from COVID-19 autopsies (23 ligand-receptor pairs in the heart, 13 in the liver, and 7 in the lung, p&lt;1e-2; <xref ref-type="fig" rid="fig6">Figure 6C–E</xref>). Among the top signaling interactions, we found expression of VEGF ligand-receptor pairs in the liver and heart (FLT4:VEGFC; VEGFA: KDR; NRP2:VEGFA; VEGFA:FLT1). In the lung, we found expression of EGFR in endothelial cells and expression of COPA and GRN in macrophages, suggesting another mechanism of cell-cell signaling between these two cell types. In the heart, we found multiple Notch ligand-receptor enriched pairs involving the expression of the Dll4 ligand in endothelial cells (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Interestingly, the expression of Notch receptors was cell-type dependent: endothelial cells expressed Notch4 and Notch1, whereas macrophages expressed Notch2 (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). A Dll4-dependent signaling mechanism involving endothelial cells and macrophages in the COVID-19 heart is potentially related to HIF-1 signaling since these pathways are known to cross-talk through multiple mechanisms (<xref ref-type="bibr" rid="bib3">Breikaa and Lilly, 2021</xref>; <xref ref-type="bibr" rid="bib64">Zheng et al., 2008</xref>).</p></sec></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><p>We generated the CTA, a single-cell atlas of six organs from autopsies of COVID-19 patients. Our study found that COVID-19 infection damages multiple organs, and our analyses reveal transcriptomic changes in various cell types across these organs. While the lungs are the most affected organ in COVID-19 infection, our data shows widespread transcriptional changes related to cell signaling across multiple organs and cell types (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Notably, we localized these signaling changes in two affected organs: the liver and heart, where we identified dysregulated insulin and HIF signaling and prominent potential macrophage-endothelial interactions (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><p>Collecting multiple organs from the same donors enabled cross-organ analysis of transcriptional responses. While some single-cell atlases have collected multiple organs in the past (<xref ref-type="bibr" rid="bib22">Jones et al., 2022</xref>), there haven’t been many efforts to do it in the context of disease (<xref ref-type="bibr" rid="bib6">Delorey et al., 2021</xref>). Here, we present a cross-organ analysis of DE in the context of COVID-19. We identified a coordinated signature in macrophages and endothelial cells by analyzing the transcriptional changes in multiple organs, which is often overlooked in other studies. These coordinated signatures between macrophages and endothelial cells may be mediated by the known effects of the dysregulated immune system in the context and sequelae of COVID-19 infection.</p><p>One limitation of our study is the limited number of high-quality sequenced cells. Despite initially targeting 1 million nuclei, most samples did not pass quality control. Another consideration is that our atlas is composed of single-nuclei samples, impeding the observation of some transcriptional effects in the cytoplasm due to technological limitations. However, our dataset should be complementary to the current body of knowledge regarding COVID-19, and we expect that future analyses, including multiple datasets (<xref ref-type="bibr" rid="bib63">Zhang and Li, 2022</xref>), will overcome these limitations.</p><p>The effects of COVID-19 on the human body are yet to be fully understood, and we need comprehensive maps of the changes at the transcriptional and proteomic levels. The CTA and the corresponding analyses represent an integrated effort toward understanding the effects of this disease from an organism-wide point of view (<xref ref-type="bibr" rid="bib63">Zhang and Li, 2022</xref>). More generally, we expect some of the computational analysis presented in this study to be generalized to other cell atlas datasets to reveal systemic transcriptional signatures of disease by analyzing the responses of individual cells while considering the global context of the human body. Our findings have important implications for understanding the long-term effects of COVID-19 on various organs and the increased risk of diseases linked to COVID-19 infection. For example, insulin signaling dysregulation may contribute to developing diabetes in COVID-19 patients (<xref ref-type="bibr" rid="bib33">Mishra and Dey, 2021</xref>). Long-COVID, which appears to be a complex set of symptoms with variable organ dysfunction (<xref ref-type="bibr" rid="bib35">Morrow et al., 2022</xref>), may also be informed by our understanding of cellular changes across multiple tissues.</p><p>The CTA represents a valuable resource that will enable further analysis, particularly cross-organ comparisons. Our data is fully available to the community through an interactive web portal from which users can directly explore the transcriptional signatures or download the count matrices for in-depth analysis. Overall, the CTA contributes to our molecular understanding of the effects of severe SARS-CoV2 infection across multiple organs and cell types.</p></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Investigation, Software, Supervision, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Software, Validation, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Methodology</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Software, Investigation, Visualization</p></fn><fn fn-type="con" id="con7"><p>Supervision</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Funding acquisition, Investigation</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Data curation, Funding acquisition, Investigation, Project administration</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Data curation, Funding acquisition, Investigation</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Writing – original draft</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Organs from post-mortem control individuals and patients with COVID-19 were obtained at the time of autopsy from the University of California, San Francisco Medical Center, and the Saarland University Hospital Institute for Neuropathology. In both institutions, autopsies are exempt from local Institutional Review Board and Committee on Human Research oversight. All autopsies performed have informed consent from legal next of kin for use of tissues for research purposes.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Patient characteristics.</title></caption><media xlink:href="elife-81090-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Differential gene expression COVID-19 vs. healthy across all cell types in the COVID Tissue Atlas (CTA).</title></caption><media xlink:href="elife-81090-supp2-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Pathway enrichment analysis for all cell types in COVID Tissue Atlas (CTA).</title></caption><media xlink:href="elife-81090-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Shared DGE (differential gene expression) signatures in macrophages and endothelial.</title></caption><media xlink:href="elife-81090-supp4-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Upregulated pathways in the shared transcriptional response of macrophages.</title></caption><media xlink:href="elife-81090-supp5-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Upregulated pathways in the shared transcriptional response of endothelial cells.</title></caption><media xlink:href="elife-81090-supp6-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Shared transcriptional signatures in macrophages and endothelial cells in the Broad atlas and their overlap with the COVID Tissue Atlas (CTA).</title></caption><media xlink:href="elife-81090-supp7-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-81090-transrepform1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed in this study is available through the <ext-link ext-link-type="uri" xlink:href="http://covid-tissue-atlas.ds.czbiohub.org/">COVID Tissue Atlas (CTA) portal website</ext-link>. All code used in this study, including Jupyter notebooks for pre-processing, analysis, and visualization, is available on the <ext-link ext-link-type="uri" xlink:href="https://github.com/czbiohub-sf/CovidTissueAtlas">CTA GitHub repository</ext-link> (copy archived at <xref ref-type="bibr" rid="bib14">Granados and Pisco, 2023</xref>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><collab>COVID Tissue Atlas Consortium</collab></person-group><year iso-8601-date="2022">2022</year><data-title>COVID Tissue Atlas</data-title><source>CTA</source><pub-id pub-id-type="accession" xlink:href="https://covid-tissue-atlas.ds.czbiohub.org">covid-tissue</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Regev</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>COVID-19 tissue atlases reveal SARS-COV-2 pathology and cellular targets</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE171668">GSE171668</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>TS</given-names></name><name><surname>Schupp</surname><given-names>JC</given-names></name><name><surname>Poli</surname><given-names>S</given-names></name><name><surname>Ayaub</surname><given-names>EA</given-names></name><name><surname>Neumark</surname><given-names>N</given-names></name><name><surname>Ahangari</surname><given-names>F</given-names></name><name><surname>Chu</surname><given-names>SG</given-names></name><name><surname>Raby</surname><given-names>BA</given-names></name><name><surname>DeIuliis</surname><given-names>G</given-names></name><name><surname>Januszyk</surname><given-names>M</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Arnett</surname><given-names>HA</given-names></name><name><surname>Siddiqui</surname><given-names>A</given-names></name><name><surname>Washko</surname><given-names>GR</given-names></name><name><surname>Homer</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Rosas</surname><given-names>IO</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaba1983</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba1983</pub-id><pub-id pub-id-type="pmid">32832599</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>CE</given-names></name><name><surname>Koyama</surname><given-names>AK</given-names></name><name><surname>Alvarez</surname><given-names>P</given-names></name><name><surname>Chow</surname><given-names>W</given-names></name><name><surname>Lundeen</surname><given-names>EA</given-names></name><name><surname>Perrine</surname><given-names>CG</given-names></name><name><surname>Pavkov</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Risk for Newly Diagnosed Diabetes &gt;30 Days After SARS-CoV-2 Infection Among Persons Aged MMWR</article-title><source>Morbidity and Mortality Weekly Report</source><volume>71</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm7102e2</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breikaa</surname><given-names>RM</given-names></name><name><surname>Lilly</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The Notch Pathway: A Link Between COVID-19 Pathophysiology and Its Cardiovascular Complications</article-title><source>Frontiers in Cardiovascular Medicine</source><volume>8</volume><elocation-id>681948</elocation-id><pub-id pub-id-type="doi">10.3389/fcvm.2021.681948</pub-id><pub-id pub-id-type="pmid">34124207</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>TTS</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The tabula sapiens: a multiple organ single cell transcriptomic atlas of humans</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.07.19.452956</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deinhardt-Emmer</surname><given-names>S</given-names></name><name><surname>Wittschieber</surname><given-names>D</given-names></name><name><surname>Sanft</surname><given-names>J</given-names></name><name><surname>Kleemann</surname><given-names>S</given-names></name><name><surname>Elschner</surname><given-names>S</given-names></name><name><surname>Haupt</surname><given-names>KF</given-names></name><name><surname>Vau</surname><given-names>V</given-names></name><name><surname>Häring</surname><given-names>C</given-names></name><name><surname>Rödel</surname><given-names>J</given-names></name><name><surname>Henke</surname><given-names>A</given-names></name><name><surname>Ehrhardt</surname><given-names>C</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Philipp</surname><given-names>M</given-names></name><name><surname>Gaßler</surname><given-names>N</given-names></name><name><surname>Nietzsche</surname><given-names>S</given-names></name><name><surname>Löffler</surname><given-names>B</given-names></name><name><surname>Mall</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage</article-title><source>eLife</source><volume>10</volume><elocation-id>e60361</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60361</pub-id><pub-id pub-id-type="pmid">33781385</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delorey</surname><given-names>TM</given-names></name><name><surname>Ziegler</surname><given-names>CGK</given-names></name><name><surname>Heimberg</surname><given-names>G</given-names></name><name><surname>Normand</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Segerstolpe</surname><given-names>Å</given-names></name><name><surname>Abbondanza</surname><given-names>D</given-names></name><name><surname>Fleming</surname><given-names>SJ</given-names></name><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Montoro</surname><given-names>DT</given-names></name><name><surname>Jagadeesh</surname><given-names>KA</given-names></name><name><surname>Dey</surname><given-names>KK</given-names></name><name><surname>Sen</surname><given-names>P</given-names></name><name><surname>Slyper</surname><given-names>M</given-names></name><name><surname>Pita-Juárez</surname><given-names>YH</given-names></name><name><surname>Phillips</surname><given-names>D</given-names></name><name><surname>Biermann</surname><given-names>J</given-names></name><name><surname>Bloom-Ackermann</surname><given-names>Z</given-names></name><name><surname>Barkas</surname><given-names>N</given-names></name><name><surname>Ganna</surname><given-names>A</given-names></name><name><surname>Gomez</surname><given-names>J</given-names></name><name><surname>Melms</surname><given-names>JC</given-names></name><name><surname>Katsyv</surname><given-names>I</given-names></name><name><surname>Normandin</surname><given-names>E</given-names></name><name><surname>Naderi</surname><given-names>P</given-names></name><name><surname>Popov</surname><given-names>YV</given-names></name><name><surname>Raju</surname><given-names>SS</given-names></name><name><surname>Niezen</surname><given-names>S</given-names></name><name><surname>Tsai</surname><given-names>LT-Y</given-names></name><name><surname>Siddle</surname><given-names>KJ</given-names></name><name><surname>Sud</surname><given-names>M</given-names></name><name><surname>Tran</surname><given-names>VM</given-names></name><name><surname>Vellarikkal</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Amir-Zilberstein</surname><given-names>L</given-names></name><name><surname>Atri</surname><given-names>DS</given-names></name><name><surname>Beechem</surname><given-names>J</given-names></name><name><surname>Brook</surname><given-names>OR</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Divakar</surname><given-names>P</given-names></name><name><surname>Dorceus</surname><given-names>P</given-names></name><name><surname>Engreitz</surname><given-names>JM</given-names></name><name><surname>Essene</surname><given-names>A</given-names></name><name><surname>Fitzgerald</surname><given-names>DM</given-names></name><name><surname>Fropf</surname><given-names>R</given-names></name><name><surname>Gazal</surname><given-names>S</given-names></name><name><surname>Gould</surname><given-names>J</given-names></name><name><surname>Grzyb</surname><given-names>J</given-names></name><name><surname>Harvey</surname><given-names>T</given-names></name><name><surname>Hecht</surname><given-names>J</given-names></name><name><surname>Hether</surname><given-names>T</given-names></name><name><surname>Jané-Valbuena</surname><given-names>J</given-names></name><name><surname>Leney-Greene</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>McCabe</surname><given-names>C</given-names></name><name><surname>McLoughlin</surname><given-names>DE</given-names></name><name><surname>Miller</surname><given-names>EM</given-names></name><name><surname>Muus</surname><given-names>C</given-names></name><name><surname>Niemi</surname><given-names>M</given-names></name><name><surname>Padera</surname><given-names>R</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Pant</surname><given-names>D</given-names></name><name><surname>Pe’er</surname><given-names>C</given-names></name><name><surname>Pfiffner-Borges</surname><given-names>J</given-names></name><name><surname>Pinto</surname><given-names>CJ</given-names></name><name><surname>Plaisted</surname><given-names>J</given-names></name><name><surname>Reeves</surname><given-names>J</given-names></name><name><surname>Ross</surname><given-names>M</given-names></name><name><surname>Rudy</surname><given-names>M</given-names></name><name><surname>Rueckert</surname><given-names>EH</given-names></name><name><surname>Siciliano</surname><given-names>M</given-names></name><name><surname>Sturm</surname><given-names>A</given-names></name><name><surname>Todres</surname><given-names>E</given-names></name><name><surname>Waghray</surname><given-names>A</given-names></name><name><surname>Warren</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zollinger</surname><given-names>DR</given-names></name><name><surname>Cosimi</surname><given-names>L</given-names></name><name><surname>Gupta</surname><given-names>RM</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name><name><surname>Hibshoosh</surname><given-names>H</given-names></name><name><surname>Hide</surname><given-names>W</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Riedel</surname><given-names>S</given-names></name><name><surname>Szabo</surname><given-names>G</given-names></name><name><surname>Tickle</surname><given-names>TL</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Hung</surname><given-names>D</given-names></name><name><surname>Sabeti</surname><given-names>PC</given-names></name><name><surname>Novak</surname><given-names>R</given-names></name><name><surname>Rogers</surname><given-names>R</given-names></name><name><surname>Ingber</surname><given-names>DE</given-names></name><name><surname>Jiang</surname><given-names>ZG</given-names></name><name><surname>Juric</surname><given-names>D</given-names></name><name><surname>Babadi</surname><given-names>M</given-names></name><name><surname>Farhi</surname><given-names>SL</given-names></name><name><surname>Izar</surname><given-names>B</given-names></name><name><surname>Stone</surname><given-names>JR</given-names></name><name><surname>Vlachos</surname><given-names>IS</given-names></name><name><surname>Solomon</surname><given-names>IH</given-names></name><name><surname>Ashenberg</surname><given-names>O</given-names></name><name><surname>Porter</surname><given-names>CBM</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Villani</surname><given-names>A-C</given-names></name><name><surname>Rozenblatt-Rosen</surname><given-names>O</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets</article-title><source>Nature</source><volume>595</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03570-8</pub-id><pub-id pub-id-type="pmid">33915569</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>E</given-names></name><name><surname>Du</surname><given-names>H</given-names></name><name><surname>Gardner</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An interactive web-based dashboard to track COVID-19 in real time</article-title><source>The Lancet. Infectious Diseases</source><volume>20</volume><fpage>533</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30120-1</pub-id><pub-id pub-id-type="pmid">32087114</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efremova</surname><given-names>M</given-names></name><name><surname>Vento-Tormo</surname><given-names>M</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Vento-Tormo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes</article-title><source>Nature Protocols</source><volume>15</volume><fpage>1484</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0292-x</pub-id><pub-id pub-id-type="pmid">32103204</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farahani</surname><given-names>M</given-names></name><name><surname>Niknam</surname><given-names>Z</given-names></name><name><surname>Mohammadi Amirabad</surname><given-names>L</given-names></name><name><surname>Amiri-Dashatan</surname><given-names>N</given-names></name><name><surname>Koushki</surname><given-names>M</given-names></name><name><surname>Nemati</surname><given-names>M</given-names></name><name><surname>Danesh Pouya</surname><given-names>F</given-names></name><name><surname>Rezaei-Tavirani</surname><given-names>M</given-names></name><name><surname>Rasmi</surname><given-names>Y</given-names></name><name><surname>Tayebi</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets</article-title><source>Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie</source><volume>145</volume><elocation-id>112420</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2021.112420</pub-id><pub-id pub-id-type="pmid">34801852</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fard</surname><given-names>MB</given-names></name><name><surname>Fard</surname><given-names>SB</given-names></name><name><surname>Ramazi</surname><given-names>S</given-names></name><name><surname>Atashi</surname><given-names>A</given-names></name><name><surname>Eslamifar</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity</article-title><source>Thrombosis Journal</source><volume>19</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.1186/s12959-021-00311-9</pub-id><pub-id pub-id-type="pmid">34425822</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finak</surname><given-names>G</given-names></name><name><surname>McDavid</surname><given-names>A</given-names></name><name><surname>Yajima</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Gersuk</surname><given-names>V</given-names></name><name><surname>Shalek</surname><given-names>AK</given-names></name><name><surname>Slichter</surname><given-names>CK</given-names></name><name><surname>Miller</surname><given-names>HW</given-names></name><name><surname>McElrath</surname><given-names>MJ</given-names></name><name><surname>Prlic</surname><given-names>M</given-names></name><name><surname>Linsley</surname><given-names>PS</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>278</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0844-5</pub-id><pub-id pub-id-type="pmid">26653891</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>SJ</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Babadi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CellBender remove-background: a deep generative model for unsupervised removal of background noise from scrna-seq datasets</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/791699</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govender</surname><given-names>N</given-names></name><name><surname>Khaliq</surname><given-names>OP</given-names></name><name><surname>Moodley</surname><given-names>J</given-names></name><name><surname>Naicker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Insulin resistance in COVID-19 and diabetes</article-title><source>Primary Care Diabetes</source><volume>15</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1016/j.pcd.2021.04.004</pub-id><pub-id pub-id-type="pmid">33849817</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Granados</surname><given-names>AA</given-names></name><name><surname>Pisco</surname><given-names>AO</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Covid tissue Atlas</data-title><version designator="swh:1:rev:ce35042ffa58842f2191277f4235453cce94f277">swh:1:rev:ce35042ffa58842f2191277f4235453cce94f277</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:6addd7e428f19d338065d948e03c283dfce49db7;origin=https://github.com/czbiohub-sf/CovidTissueAtlas;visit=swh:1:snp:7e098064133ff5c20d0a967fc59975c3409d1a6d;anchor=swh:1:rev:ce35042ffa58842f2191277f4235453cce94f277">https://archive.softwareheritage.org/swh:1:dir:6addd7e428f19d338065d948e03c283dfce49db7;origin=https://github.com/czbiohub-sf/CovidTissueAtlas;visit=swh:1:snp:7e098064133ff5c20d0a967fc59975c3409d1a6d;anchor=swh:1:rev:ce35042ffa58842f2191277f4235453cce94f277</ext-link></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griss</surname><given-names>J</given-names></name><name><surname>Viteri</surname><given-names>G</given-names></name><name><surname>Sidiropoulos</surname><given-names>K</given-names></name><name><surname>Nguyen</surname><given-names>V</given-names></name><name><surname>Fabregat</surname><given-names>A</given-names></name><name><surname>Hermjakob</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>ReactomeGSA - Efficient Multi-Omics Comparative Pathway Analysis</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>19</volume><fpage>2115</fpage><lpage>2125</lpage><pub-id pub-id-type="doi">10.1074/mcp.TIR120.002155</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habermann</surname><given-names>AC</given-names></name><name><surname>Gutierrez</surname><given-names>AJ</given-names></name><name><surname>Bui</surname><given-names>LT</given-names></name><name><surname>Yahn</surname><given-names>SL</given-names></name><name><surname>Winters</surname><given-names>NI</given-names></name><name><surname>Calvi</surname><given-names>CL</given-names></name><name><surname>Peter</surname><given-names>L</given-names></name><name><surname>Chung</surname><given-names>M-I</given-names></name><name><surname>Taylor</surname><given-names>CJ</given-names></name><name><surname>Jetter</surname><given-names>C</given-names></name><name><surname>Raju</surname><given-names>L</given-names></name><name><surname>Roberson</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>L</given-names></name><name><surname>Sucre</surname><given-names>JMS</given-names></name><name><surname>Richmond</surname><given-names>BW</given-names></name><name><surname>Serezani</surname><given-names>AP</given-names></name><name><surname>McDonnell</surname><given-names>WJ</given-names></name><name><surname>Mallal</surname><given-names>SB</given-names></name><name><surname>Bacchetta</surname><given-names>MJ</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Shaver</surname><given-names>CM</given-names></name><name><surname>Ware</surname><given-names>LB</given-names></name><name><surname>Bremner</surname><given-names>R</given-names></name><name><surname>Walia</surname><given-names>R</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name><name><surname>Banovich</surname><given-names>NE</given-names></name><name><surname>Kropski</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaba1972</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba1972</pub-id><pub-id pub-id-type="pmid">32832598</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>AG</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mechanisms of SARS-CoV-2 Transmission and Pathogenesis</article-title><source>Trends in Immunology</source><volume>41</volume><fpage>1100</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.1016/j.it.2020.10.004</pub-id><pub-id pub-id-type="pmid">33132005</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname><given-names>MZ</given-names></name><name><surname>Islam</surname><given-names>S</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Kawai</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients</article-title><source>Computers in Biology and Medicine</source><volume>137</volume><elocation-id>104792</elocation-id><pub-id pub-id-type="doi">10.1016/j.compbiomed.2021.104792</pub-id><pub-id pub-id-type="pmid">34478921</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The cytokine storm and COVID-19</article-title><source>Journal of Medical Virology</source><volume>93</volume><fpage>250</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1002/jmv.26232</pub-id><pub-id pub-id-type="pmid">32592501</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huertas</surname><given-names>A</given-names></name><name><surname>Montani</surname><given-names>D</given-names></name><name><surname>Savale</surname><given-names>L</given-names></name><name><surname>Pichon</surname><given-names>J</given-names></name><name><surname>Tu</surname><given-names>L</given-names></name><name><surname>Parent</surname><given-names>F</given-names></name><name><surname>Guignabert</surname><given-names>C</given-names></name><name><surname>Humbert</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Endothelial cell dysfunction: A major player in SARS-CoV-2 infection (COVID-19)?</article-title><source>The European Respiratory Journal</source><volume>56</volume><elocation-id>2001634</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.01634-2020</pub-id><pub-id pub-id-type="pmid">32554538</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izumi</surname><given-names>N</given-names></name><name><surname>Helker</surname><given-names>C</given-names></name><name><surname>Ehling</surname><given-names>M</given-names></name><name><surname>Behrens</surname><given-names>A</given-names></name><name><surname>Herzog</surname><given-names>W</given-names></name><name><surname>Adams</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fbxw7 controls angiogenesis by regulating endothelial Notch activity</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e41116</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0041116</pub-id><pub-id pub-id-type="pmid">22848434</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>RC</given-names></name><name><surname>Karkanias</surname><given-names>J</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name><name><surname>Pisco</surname><given-names>AO</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Salzman</surname><given-names>J</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Bulthaup</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>P</given-names></name><name><surname>Harper</surname><given-names>W</given-names></name><name><surname>Hemenez</surname><given-names>M</given-names></name><name><surname>Ponnusamy</surname><given-names>R</given-names></name><name><surname>Salehi</surname><given-names>A</given-names></name><name><surname>Sanagavarapu</surname><given-names>BA</given-names></name><name><surname>Spallino</surname><given-names>E</given-names></name><name><surname>Aaron</surname><given-names>KA</given-names></name><name><surname>Concepcion</surname><given-names>W</given-names></name><name><surname>Gardner</surname><given-names>JM</given-names></name><name><surname>Kelly</surname><given-names>B</given-names></name><name><surname>Neidlinger</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Crasta</surname><given-names>S</given-names></name><name><surname>Kolluru</surname><given-names>S</given-names></name><name><surname>Morri</surname><given-names>M</given-names></name><name><surname>Pisco</surname><given-names>AO</given-names></name><name><surname>Tan</surname><given-names>SY</given-names></name><name><surname>Travaglini</surname><given-names>KJ</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Alcántara-Hernández</surname><given-names>M</given-names></name><name><surname>Almanzar</surname><given-names>N</given-names></name><name><surname>Antony</surname><given-names>J</given-names></name><name><surname>Beyersdorf</surname><given-names>B</given-names></name><name><surname>Burhan</surname><given-names>D</given-names></name><name><surname>Calcuttawala</surname><given-names>K</given-names></name><name><surname>Carter</surname><given-names>MM</given-names></name><name><surname>Chan</surname><given-names>CKF</given-names></name><name><surname>Chang</surname><given-names>CA</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><name><surname>Colville</surname><given-names>A</given-names></name><name><surname>Crasta</surname><given-names>S</given-names></name><name><surname>Culver</surname><given-names>RN</given-names></name><name><surname>Cvijović</surname><given-names>I</given-names></name><name><surname>D’Amato</surname><given-names>G</given-names></name><name><surname>Ezran</surname><given-names>C</given-names></name><name><surname>Galdos</surname><given-names>FX</given-names></name><name><surname>Gillich</surname><given-names>A</given-names></name><name><surname>Goodyer</surname><given-names>WR</given-names></name><name><surname>Hang</surname><given-names>Y</given-names></name><name><surname>Hayashi</surname><given-names>A</given-names></name><name><surname>Houshdaran</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Irwin</surname><given-names>JC</given-names></name><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Juanico</surname><given-names>JV</given-names></name><name><surname>Kershner</surname><given-names>AM</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Kiss</surname><given-names>B</given-names></name><name><surname>Kolluru</surname><given-names>S</given-names></name><name><surname>Kong</surname><given-names>W</given-names></name><name><surname>Kumar</surname><given-names>ME</given-names></name><name><surname>Kuo</surname><given-names>AH</given-names></name><name><surname>Leylek</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Loeb</surname><given-names>GB</given-names></name><name><surname>Lu</surname><given-names>W-J</given-names></name><name><surname>Mantri</surname><given-names>S</given-names></name><name><surname>Markovic</surname><given-names>M</given-names></name><name><surname>McAlpine</surname><given-names>PL</given-names></name><name><surname>de Morree</surname><given-names>A</given-names></name><name><surname>Morri</surname><given-names>M</given-names></name><name><surname>Mrouj</surname><given-names>K</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Muser</surname><given-names>T</given-names></name><name><surname>Neuhöfer</surname><given-names>P</given-names></name><name><surname>Nguyen</surname><given-names>TD</given-names></name><name><surname>Perez</surname><given-names>K</given-names></name><name><surname>Phansalkar</surname><given-names>R</given-names></name><name><surname>Pisco</surname><given-names>AO</given-names></name><name><surname>Puluca</surname><given-names>N</given-names></name><name><surname>Qi</surname><given-names>Z</given-names></name><name><surname>Rao</surname><given-names>P</given-names></name><name><surname>Raquer-McKay</surname><given-names>H</given-names></name><name><surname>Schaum</surname><given-names>N</given-names></name><name><surname>Scott</surname><given-names>B</given-names></name><name><surname>Seddighzadeh</surname><given-names>B</given-names></name><name><surname>Segal</surname><given-names>J</given-names></name><name><surname>Sen</surname><given-names>S</given-names></name><name><surname>Sikandar</surname><given-names>S</given-names></name><name><surname>Spencer</surname><given-names>SP</given-names></name><name><surname>Steffes</surname><given-names>LC</given-names></name><name><surname>Subramaniam</surname><given-names>VR</given-names></name><name><surname>Swarup</surname><given-names>A</given-names></name><name><surname>Swift</surname><given-names>M</given-names></name><name><surname>Travaglini</surname><given-names>KJ</given-names></name><name><surname>Van Treuren</surname><given-names>W</given-names></name><name><surname>Trimm</surname><given-names>E</given-names></name><name><surname>Veizades</surname><given-names>S</given-names></name><name><surname>Vijayakumar</surname><given-names>S</given-names></name><name><surname>Vo</surname><given-names>KC</given-names></name><name><surname>Vorperian</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Weinstein</surname><given-names>HNW</given-names></name><name><surname>Winkler</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>TTH</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Yung</surname><given-names>AR</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Detweiler</surname><given-names>AM</given-names></name><name><surname>Mekonen</surname><given-names>H</given-names></name><name><surname>Neff</surname><given-names>NF</given-names></name><name><surname>Sit</surname><given-names>RV</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Bean</surname><given-names>GR</given-names></name><name><surname>Charu</surname><given-names>V</given-names></name><name><surname>Forgó</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>BA</given-names></name><name><surname>Ozawa</surname><given-names>MG</given-names></name><name><surname>Silva</surname><given-names>O</given-names></name><name><surname>Tan</surname><given-names>SY</given-names></name><name><surname>Toland</surname><given-names>A</given-names></name><name><surname>Vemuri</surname><given-names>VNP</given-names></name><name><surname>Afik</surname><given-names>S</given-names></name><name><surname>Awayan</surname><given-names>K</given-names></name><name><surname>Botvinnik</surname><given-names>OB</given-names></name><name><surname>Byrne</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Dehghannasiri</surname><given-names>R</given-names></name><name><surname>Detweiler</surname><given-names>AM</given-names></name><name><surname>Gayoso</surname><given-names>A</given-names></name><name><surname>Granados</surname><given-names>AA</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Mahmoudabadi</surname><given-names>G</given-names></name><name><surname>McGeever</surname><given-names>A</given-names></name><name><surname>de Morree</surname><given-names>A</given-names></name><name><surname>Olivieri</surname><given-names>JE</given-names></name><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Pisco</surname><given-names>AO</given-names></name><name><surname>Ravikumar</surname><given-names>N</given-names></name><name><surname>Salzman</surname><given-names>J</given-names></name><name><surname>Stanley</surname><given-names>G</given-names></name><name><surname>Swift</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Tarashansky</surname><given-names>AJ</given-names></name><name><surname>Vanheusden</surname><given-names>R</given-names></name><name><surname>Vorperian</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xing</surname><given-names>G</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Alcántara-Hernández</surname><given-names>M</given-names></name><name><surname>Antony</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>CKF</given-names></name><name><surname>Chang</surname><given-names>CA</given-names></name><name><surname>Colville</surname><given-names>A</given-names></name><name><surname>Crasta</surname><given-names>S</given-names></name><name><surname>Culver</surname><given-names>R</given-names></name><name><surname>Dethlefsen</surname><given-names>L</given-names></name><name><surname>Ezran</surname><given-names>C</given-names></name><name><surname>Gillich</surname><given-names>A</given-names></name><name><surname>Hang</surname><given-names>Y</given-names></name><name><surname>Ho</surname><given-names>P-Y</given-names></name><name><surname>Irwin</surname><given-names>JC</given-names></name><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Kershner</surname><given-names>AM</given-names></name><name><surname>Kong</surname><given-names>W</given-names></name><name><surname>Kumar</surname><given-names>ME</given-names></name><name><surname>Kuo</surname><given-names>AH</given-names></name><name><surname>Leylek</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Loeb</surname><given-names>GB</given-names></name><name><surname>Lu</surname><given-names>W-J</given-names></name><name><surname>Maltzman</surname><given-names>JS</given-names></name><name><surname>Metzger</surname><given-names>RJ</given-names></name><name><surname>de Morree</surname><given-names>A</given-names></name><name><surname>Neuhöfer</surname><given-names>P</given-names></name><name><surname>Perez</surname><given-names>K</given-names></name><name><surname>Phansalkar</surname><given-names>R</given-names></name><name><surname>Qi</surname><given-names>Z</given-names></name><name><surname>Rao</surname><given-names>P</given-names></name><name><surname>Raquer-McKay</surname><given-names>H</given-names></name><name><surname>Sasagawa</surname><given-names>K</given-names></name><name><surname>Scott</surname><given-names>B</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Spencer</surname><given-names>SP</given-names></name><name><surname>Swarup</surname><given-names>A</given-names></name><name><surname>Swift</surname><given-names>M</given-names></name><name><surname>Travaglini</surname><given-names>KJ</given-names></name><name><surname>Trimm</surname><given-names>E</given-names></name><name><surname>Veizades</surname><given-names>S</given-names></name><name><surname>Vijayakumar</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Winkler</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Yung</surname><given-names>AR</given-names></name><name><surname>Artandi</surname><given-names>SE</given-names></name><name><surname>Beachy</surname><given-names>PA</given-names></name><name><surname>Clarke</surname><given-names>MF</given-names></name><name><surname>Giudice</surname><given-names>LC</given-names></name><name><surname>Huang</surname><given-names>FW</given-names></name><name><surname>Huang</surname><given-names>KC</given-names></name><name><surname>Idoyaga</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Krasnow</surname><given-names>M</given-names></name><name><surname>Kuo</surname><given-names>CS</given-names></name><name><surname>Nguyen</surname><given-names>P</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Rando</surname><given-names>TA</given-names></name><name><surname>Red-Horse</surname><given-names>K</given-names></name><name><surname>Reiter</surname><given-names>J</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name><name><surname>Sonnenburg</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>SM</given-names></name><name><surname>Wyss-Coray</surname><given-names>T</given-names></name><collab>Tabula Sapiens Consortium*</collab></person-group><year iso-8601-date="2022">2022</year><article-title>The tabula sapiens: a multiple-organ, single-cell transcriptomic atlas of humans</article-title><source>Science</source><volume>376</volume><elocation-id>eabl4896</elocation-id><pub-id pub-id-type="doi">10.1126/science.abl4896</pub-id><pub-id pub-id-type="pmid">35549404</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>KEGG as a reference resource for gene and protein annotation</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D457</fpage><lpage>D462</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1070</pub-id><pub-id pub-id-type="pmid">26476454</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiriya</surname><given-names>JJ</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Brumwell</surname><given-names>A</given-names></name><name><surname>Cassandras</surname><given-names>M</given-names></name><name><surname>Le Saux</surname><given-names>CJ</given-names></name><name><surname>Cohen</surname><given-names>M</given-names></name><name><surname>Alysandratos</surname><given-names>K-D</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Wolters</surname><given-names>P</given-names></name><name><surname>Matthay</surname><given-names>M</given-names></name><name><surname>Kotton</surname><given-names>DN</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Peng</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5<sup>+</sup> basal cells</article-title><source>Nature Cell Biology</source><volume>24</volume><fpage>10</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/s41556-021-00809-4</pub-id><pub-id pub-id-type="pmid">34969962</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klover</surname><given-names>PJ</given-names></name><name><surname>Mooney</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Hepatocytes: critical for glucose homeostasis</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>36</volume><fpage>753</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2003.10.002</pub-id><pub-id pub-id-type="pmid">15061128</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>VEGF-D: A novel biomarker for detection of COVID-19 progression</article-title><source>Critical Care</source><volume>24</volume><elocation-id>373</elocation-id><pub-id pub-id-type="doi">10.1186/s13054-020-03079-y</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Litviňuková</surname><given-names>M</given-names></name><name><surname>Talavera-López</surname><given-names>C</given-names></name><name><surname>Maatz</surname><given-names>H</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Worth</surname><given-names>CL</given-names></name><name><surname>Lindberg</surname><given-names>EL</given-names></name><name><surname>Kanda</surname><given-names>M</given-names></name><name><surname>Polanski</surname><given-names>K</given-names></name><name><surname>Heinig</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Nadelmann</surname><given-names>ER</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><name><surname>Tuck</surname><given-names>L</given-names></name><name><surname>Fasouli</surname><given-names>ES</given-names></name><name><surname>DeLaughter</surname><given-names>DM</given-names></name><name><surname>McDonough</surname><given-names>B</given-names></name><name><surname>Wakimoto</surname><given-names>H</given-names></name><name><surname>Gorham</surname><given-names>JM</given-names></name><name><surname>Samari</surname><given-names>S</given-names></name><name><surname>Mahbubani</surname><given-names>KT</given-names></name><name><surname>Saeb-Parsy</surname><given-names>K</given-names></name><name><surname>Patone</surname><given-names>G</given-names></name><name><surname>Boyle</surname><given-names>JJ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Viveiros</surname><given-names>A</given-names></name><name><surname>Oudit</surname><given-names>GY</given-names></name><name><surname>Bayraktar</surname><given-names>OA</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Noseda</surname><given-names>M</given-names></name><name><surname>Hubner</surname><given-names>N</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cells of the adult human heart</article-title><source>Nature</source><volume>588</volume><fpage>466</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2797-4</pub-id><pub-id pub-id-type="pmid">32971526</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Regier</surname><given-names>J</given-names></name><name><surname>Cole</surname><given-names>MB</given-names></name><name><surname>Jordan</surname><given-names>MI</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Deep generative modeling for single-cell transcriptomics</article-title><source>Nature Methods</source><volume>15</volume><fpage>1053</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1038/s41592-018-0229-2</pub-id><pub-id pub-id-type="pmid">30504886</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McConnell</surname><given-names>MJ</given-names></name><name><surname>Kawaguchi</surname><given-names>N</given-names></name><name><surname>Kondo</surname><given-names>R</given-names></name><name><surname>Sonzogni</surname><given-names>A</given-names></name><name><surname>Licini</surname><given-names>L</given-names></name><name><surname>Valle</surname><given-names>C</given-names></name><name><surname>Bonaffini</surname><given-names>PA</given-names></name><name><surname>Sironi</surname><given-names>S</given-names></name><name><surname>Alessio</surname><given-names>MG</given-names></name><name><surname>Previtali</surname><given-names>G</given-names></name><name><surname>Seghezzi</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>AI</given-names></name><name><surname>Pine</surname><given-names>AB</given-names></name><name><surname>Chun</surname><given-names>HJ</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Fernandez-Hernando</surname><given-names>C</given-names></name><name><surname>Qing</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Price</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Utsumi</surname><given-names>T</given-names></name><name><surname>Hwa</surname><given-names>J</given-names></name><name><surname>Strazzabosco</surname><given-names>M</given-names></name><name><surname>Iwakiri</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy</article-title><source>Journal of Hepatology</source><volume>75</volume><fpage>647</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2021.04.050</pub-id><pub-id pub-id-type="pmid">33991637</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>L</given-names></name><name><surname>Healy</surname><given-names>J</given-names></name><name><surname>Saul</surname><given-names>N</given-names></name><name><surname>Großberger</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>UMAP: uniform manifold approximation and projection</article-title><source>Journal of Open Source Software</source><volume>3</volume><elocation-id>861</elocation-id><pub-id pub-id-type="doi">10.21105/joss.00861</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melms</surname><given-names>JC</given-names></name><name><surname>Biermann</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><name><surname>Tagore</surname><given-names>S</given-names></name><name><surname>Katsyv</surname><given-names>I</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Amin</surname><given-names>AD</given-names></name><name><surname>Schapiro</surname><given-names>D</given-names></name><name><surname>Frangieh</surname><given-names>CJ</given-names></name><name><surname>Luoma</surname><given-names>AM</given-names></name><name><surname>Filliol</surname><given-names>A</given-names></name><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Ravichandran</surname><given-names>H</given-names></name><name><surname>Clausi</surname><given-names>MG</given-names></name><name><surname>Alba</surname><given-names>GA</given-names></name><name><surname>Rogava</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Ho</surname><given-names>P</given-names></name><name><surname>Montoro</surname><given-names>DT</given-names></name><name><surname>Kornberg</surname><given-names>AE</given-names></name><name><surname>Han</surname><given-names>AS</given-names></name><name><surname>Bakhoum</surname><given-names>MF</given-names></name><name><surname>Anandasabapathy</surname><given-names>N</given-names></name><name><surname>Suárez-Fariñas</surname><given-names>M</given-names></name><name><surname>Bakhoum</surname><given-names>SF</given-names></name><name><surname>Bram</surname><given-names>Y</given-names></name><name><surname>Borczuk</surname><given-names>A</given-names></name><name><surname>Guo</surname><given-names>XV</given-names></name><name><surname>Lefkowitch</surname><given-names>JH</given-names></name><name><surname>Marboe</surname><given-names>C</given-names></name><name><surname>Lagana</surname><given-names>SM</given-names></name><name><surname>Del Portillo</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>EJ</given-names></name><name><surname>Zorn</surname><given-names>E</given-names></name><name><surname>Markowitz</surname><given-names>GS</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Saqi</surname><given-names>A</given-names></name><name><surname>Hibshoosh</surname><given-names>H</given-names></name><name><surname>Que</surname><given-names>J</given-names></name><name><surname>Izar</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A molecular single-cell lung atlas of lethal COVID-19</article-title><source>Nature</source><volume>595</volume><fpage>114</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03569-1</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Muruganujan</surname><given-names>A</given-names></name><name><surname>Ebert</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D419</fpage><lpage>D426</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1038</pub-id><pub-id pub-id-type="pmid">30407594</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>D</given-names></name><name><surname>Dey</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter?</article-title><source>Biochemical Society Transactions</source><volume>49</volume><fpage>987</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1042/BST20201062</pub-id><pub-id pub-id-type="pmid">33666220</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokhtari</surname><given-names>T</given-names></name><name><surname>Hassani</surname><given-names>F</given-names></name><name><surname>Ghaffari</surname><given-names>N</given-names></name><name><surname>Ebrahimi</surname><given-names>B</given-names></name><name><surname>Yarahmadi</surname><given-names>A</given-names></name><name><surname>Hassanzadeh</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 and multiorgan failure: A narrative review on potential mechanisms</article-title><source>Journal of Molecular Histology</source><volume>51</volume><fpage>613</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1007/s10735-020-09915-3</pub-id><pub-id pub-id-type="pmid">33011887</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>AJ</given-names></name><name><surname>Sykes</surname><given-names>R</given-names></name><name><surname>McIntosh</surname><given-names>A</given-names></name><name><surname>Kamdar</surname><given-names>A</given-names></name><name><surname>Bagot</surname><given-names>C</given-names></name><name><surname>Bayes</surname><given-names>HK</given-names></name><name><surname>Blyth</surname><given-names>KG</given-names></name><name><surname>Briscoe</surname><given-names>M</given-names></name><name><surname>Bulluck</surname><given-names>H</given-names></name><name><surname>Carrick</surname><given-names>D</given-names></name><name><surname>Church</surname><given-names>C</given-names></name><name><surname>Corcoran</surname><given-names>D</given-names></name><name><surname>Findlay</surname><given-names>I</given-names></name><name><surname>Gibson</surname><given-names>VB</given-names></name><name><surname>Gillespie</surname><given-names>L</given-names></name><name><surname>Grieve</surname><given-names>D</given-names></name><name><surname>Hall Barrientos</surname><given-names>P</given-names></name><name><surname>Ho</surname><given-names>A</given-names></name><name><surname>Lang</surname><given-names>NN</given-names></name><name><surname>Lennie</surname><given-names>V</given-names></name><name><surname>Lowe</surname><given-names>DJ</given-names></name><name><surname>Macfarlane</surname><given-names>PW</given-names></name><name><surname>Mark</surname><given-names>PB</given-names></name><name><surname>Mayne</surname><given-names>KJ</given-names></name><name><surname>McConnachie</surname><given-names>A</given-names></name><name><surname>McGeoch</surname><given-names>R</given-names></name><name><surname>McGinley</surname><given-names>C</given-names></name><name><surname>McKee</surname><given-names>C</given-names></name><name><surname>Nordin</surname><given-names>S</given-names></name><name><surname>Payne</surname><given-names>A</given-names></name><name><surname>Rankin</surname><given-names>AJ</given-names></name><name><surname>Robertson</surname><given-names>KE</given-names></name><name><surname>Roditi</surname><given-names>G</given-names></name><name><surname>Ryan</surname><given-names>N</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><name><surname>Allwood-Spiers</surname><given-names>S</given-names></name><name><surname>Stobo</surname><given-names>D</given-names></name><name><surname>Touyz</surname><given-names>RM</given-names></name><name><surname>Veldtman</surname><given-names>G</given-names></name><name><surname>Watkins</surname><given-names>S</given-names></name><name><surname>Weeden</surname><given-names>S</given-names></name><name><surname>Weir</surname><given-names>RA</given-names></name><name><surname>Welsh</surname><given-names>P</given-names></name><name><surname>Wereski</surname><given-names>R</given-names></name><collab>CISCO-19 Consortium</collab><name><surname>Mangion</surname><given-names>K</given-names></name><name><surname>Berry</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A multisystem, cardio-renal investigation of post-COVID-19 illness</article-title><source>Nature Medicine</source><volume>28</volume><fpage>1303</fpage><lpage>1313</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01837-9</pub-id><pub-id pub-id-type="pmid">35606551</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muto</surname><given-names>Y</given-names></name><name><surname>Wilson</surname><given-names>PC</given-names></name><name><surname>Ledru</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Dimke</surname><given-names>H</given-names></name><name><surname>Waikar</surname><given-names>SS</given-names></name><name><surname>Humphreys</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>2190</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-22368-w</pub-id><pub-id pub-id-type="pmid">33850129</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>BioCarta</article-title><source>Biotech Software &amp; Internet Report</source><volume>2</volume><fpage>117</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1089/152791601750294344</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perissi</surname><given-names>V</given-names></name><name><surname>Scafoglio</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Ohgi</surname><given-names>KA</given-names></name><name><surname>Rose</surname><given-names>DW</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints</article-title><source>Molecular Cell</source><volume>29</volume><fpage>755</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2008.01.020</pub-id><pub-id pub-id-type="pmid">18374649</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiterer</surname><given-names>M</given-names></name><name><surname>Rajan</surname><given-names>M</given-names></name><name><surname>Gómez-Banoy</surname><given-names>N</given-names></name><name><surname>Lau</surname><given-names>JD</given-names></name><name><surname>Gomez-Escobar</surname><given-names>LG</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Gilani</surname><given-names>A</given-names></name><name><surname>Alvarez-Mulett</surname><given-names>S</given-names></name><name><surname>Sholle</surname><given-names>ET</given-names></name><name><surname>Chandar</surname><given-names>V</given-names></name><name><surname>Bram</surname><given-names>Y</given-names></name><name><surname>Hoffman</surname><given-names>K</given-names></name><name><surname>Bhardwaj</surname><given-names>P</given-names></name><name><surname>Piloco</surname><given-names>P</given-names></name><name><surname>Rubio-Navarro</surname><given-names>A</given-names></name><name><surname>Uhl</surname><given-names>S</given-names></name><name><surname>Carrau</surname><given-names>L</given-names></name><name><surname>Houhgton</surname><given-names>S</given-names></name><name><surname>Redmond</surname><given-names>D</given-names></name><name><surname>Shukla</surname><given-names>AP</given-names></name><name><surname>Goyal</surname><given-names>P</given-names></name><name><surname>Brown</surname><given-names>KA</given-names></name><name><surname>tenOever</surname><given-names>BR</given-names></name><name><surname>Alonso</surname><given-names>LC</given-names></name><name><surname>Schwartz</surname><given-names>RE</given-names></name><name><surname>Schenck</surname><given-names>EJ</given-names></name><name><surname>Safford</surname><given-names>MM</given-names></name><name><surname>Lo</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2</article-title><source>Cell Metabolism</source><volume>33</volume><elocation-id>2484</elocation-id><pub-id pub-id-type="doi">10.1016/j.cmet.2021.10.014</pub-id><pub-id pub-id-type="pmid">34879241</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riehle</surname><given-names>C</given-names></name><name><surname>Abel</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Insulin signaling and heart failure</article-title><source>Circulation Research</source><volume>118</volume><fpage>1151</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.306206</pub-id><pub-id pub-id-type="pmid">27034277</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname><given-names>P</given-names></name><name><surname>Vieceli Dalla Sega</surname><given-names>F</given-names></name><name><surname>Fortini</surname><given-names>F</given-names></name><name><surname>Marracino</surname><given-names>L</given-names></name><name><surname>Rapezzi</surname><given-names>C</given-names></name><name><surname>Ferrari</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm?</article-title><source>Basic Research in Cardiology</source><volume>115</volume><elocation-id>31</elocation-id><pub-id pub-id-type="doi">10.1007/s00395-020-0791-5</pub-id><pub-id pub-id-type="pmid">32274570</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Lanetty</surname><given-names>M</given-names></name><name><surname>Phillips</surname><given-names>WS</given-names></name><name><surname>Weis</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Transcriptome analysis of a cnidarian-dinoflagellate mutualism reveals complex modulation of host gene expression</article-title><source>BMC Genomics</source><volume>7</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-7-23</pub-id><pub-id pub-id-type="pmid">16472376</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruhl</surname><given-names>L</given-names></name><name><surname>Pink</surname><given-names>I</given-names></name><name><surname>Kühne</surname><given-names>JF</given-names></name><name><surname>Beushausen</surname><given-names>K</given-names></name><name><surname>Keil</surname><given-names>J</given-names></name><name><surname>Christoph</surname><given-names>S</given-names></name><name><surname>Sauer</surname><given-names>A</given-names></name><name><surname>Boblitz</surname><given-names>L</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>David</surname><given-names>S</given-names></name><name><surname>Jäck</surname><given-names>H-M</given-names></name><name><surname>Roth</surname><given-names>E</given-names></name><name><surname>Cornberg</surname><given-names>M</given-names></name><name><surname>Schulz</surname><given-names>TF</given-names></name><name><surname>Welte</surname><given-names>T</given-names></name><name><surname>Höper</surname><given-names>MM</given-names></name><name><surname>Falk</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks</article-title><source>Signal Transduction and Targeted Therapy</source><volume>6</volume><elocation-id>418</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-021-00819-6</pub-id><pub-id pub-id-type="pmid">34893580</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schupp</surname><given-names>JC</given-names></name><name><surname>Adams</surname><given-names>TS</given-names></name><name><surname>Cosme</surname><given-names>C</given-names><suffix>Jr</suffix></name><name><surname>Raredon</surname><given-names>MSB</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Omote</surname><given-names>N</given-names></name><name><surname>Poli</surname><given-names>S</given-names></name><name><surname>Chioccioli</surname><given-names>M</given-names></name><name><surname>Rose</surname><given-names>K-A</given-names></name><name><surname>Manning</surname><given-names>EP</given-names></name><name><surname>Sauler</surname><given-names>M</given-names></name><name><surname>DeIuliis</surname><given-names>G</given-names></name><name><surname>Ahangari</surname><given-names>F</given-names></name><name><surname>Neumark</surname><given-names>N</given-names></name><name><surname>Habermann</surname><given-names>AC</given-names></name><name><surname>Gutierrez</surname><given-names>AJ</given-names></name><name><surname>Bui</surname><given-names>LT</given-names></name><name><surname>Lafyatis</surname><given-names>R</given-names></name><name><surname>Pierce</surname><given-names>RW</given-names></name><name><surname>Meyer</surname><given-names>KB</given-names></name><name><surname>Nawijn</surname><given-names>MC</given-names></name><name><surname>Teichmann</surname><given-names>SA</given-names></name><name><surname>Banovich</surname><given-names>NE</given-names></name><name><surname>Kropski</surname><given-names>JA</given-names></name><name><surname>Niklason</surname><given-names>LE</given-names></name><name><surname>Pe’er</surname><given-names>D</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Homer</surname><given-names>RJ</given-names></name><name><surname>Rosas</surname><given-names>IO</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated single-cell atlas of endothelial cells of the human lung</article-title><source>Circulation</source><volume>144</volume><fpage>286</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.120.052318</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Hafemeister</surname><given-names>C</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of single-cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Tabula Muris Consortium</collab><collab>Overall coordination</collab><collab>Logistical coordination</collab><collab>Organ collection and processing</collab><collab>Library preparation and sequencing</collab><collab>Computational data analysis</collab><collab>Cell type annotation</collab><collab>Writing group</collab><collab>Supplemental text writing group</collab><collab>Principal investigators</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris</article-title><source>Nature</source><volume>562</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0590-4</pub-id><pub-id pub-id-type="pmid">30283141</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahir</surname><given-names>F</given-names></name><name><surname>Bin Arif</surname><given-names>T</given-names></name><name><surname>Ahmed</surname><given-names>J</given-names></name><name><surname>Malik</surname><given-names>F</given-names></name><name><surname>Khalid</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cardiac Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Review</article-title><source>Cureus</source><volume>12</volume><elocation-id>e8021</elocation-id><pub-id pub-id-type="doi">10.7759/cureus.8021</pub-id><pub-id pub-id-type="pmid">32528760</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taquet</surname><given-names>M</given-names></name><name><surname>Dercon</surname><given-names>Q</given-names></name><name><surname>Luciano</surname><given-names>S</given-names></name><name><surname>Geddes</surname><given-names>JR</given-names></name><name><surname>Husain</surname><given-names>M</given-names></name><name><surname>Harrison</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19</article-title><source>PLOS Medicine</source><volume>18</volume><elocation-id>e1003773</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pmed.1003773</pub-id><pub-id pub-id-type="pmid">34582441</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulgen</surname><given-names>E</given-names></name><name><surname>Ozisik</surname><given-names>O</given-names></name><name><surname>Sezerman</surname><given-names>OU</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>858</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00858</pub-id><pub-id pub-id-type="pmid">31608109</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zou</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The hippo pathway and viral infections</article-title><source>Frontiers in Microbiology</source><volume>10</volume><elocation-id>3033</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.03033</pub-id><pub-id pub-id-type="pmid">32038526</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Potential effects of coronaviruses on the liver: an update</article-title><source>Frontiers in Medicine</source><volume>8</volume><elocation-id>651658</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2021.651658</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>FA</given-names></name><name><surname>Angerer</surname><given-names>P</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SCANPY: large-scale single-cell gene expression data analysis</article-title><source>Genome Biology</source><volume>19</volume><elocation-id>15</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-017-1382-0</pub-id><pub-id pub-id-type="pmid">29409532</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolock</surname><given-names>SL</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Scrublet: computational identification of cell doublets in single-cell transcriptomic data</article-title><source>Cell Systems</source><volume>8</volume><fpage>281</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2018.11.005</pub-id><pub-id pub-id-type="pmid">30954476</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>McGoogan</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention</article-title><source>JAMA</source><volume>323</volume><fpage>1239</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.2648</pub-id><pub-id pub-id-type="pmid">32091533</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Al-Aly</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Risks and burdens of incident diabetes in long COVID: a cohort study</article-title><source>The Lancet. Diabetes &amp; Endocrinology</source><volume>10</volume><fpage>311</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(22)00044-4</pub-id><pub-id pub-id-type="pmid">35325624</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>E</given-names></name><name><surname>Bowe</surname><given-names>B</given-names></name><name><surname>Al-Aly</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Long-term cardiovascular outcomes of COVID-19</article-title><source>Nature Medicine</source><volume>28</volume><fpage>583</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1038/s41591-022-01689-3</pub-id><pub-id pub-id-type="pmid">35132265</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Dua</surname><given-names>K</given-names></name><name><surname>Hansbro</surname><given-names>PM</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis</article-title><source>Respiratory Research</source><volume>21</volume><elocation-id>182</elocation-id><pub-id pub-id-type="doi">10.1186/s12931-020-01445-6</pub-id><pub-id pub-id-type="pmid">32664949</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Mehlman</surname><given-names>E</given-names></name><name><surname>Regier</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>MI</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Probabilistic harmonization and annotation of single-cell transcriptomics data with deep generative models</article-title><source>Molecular Systems Biology</source><volume>17</volume><elocation-id>e9620</elocation-id><pub-id pub-id-type="doi">10.15252/msb.20209620</pub-id><pub-id pub-id-type="pmid">33491336</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Corbett</surname><given-names>SE</given-names></name><name><surname>Koga</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Johnson</surname><given-names>WE</given-names></name><name><surname>Yajima</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Decontamination of ambient RNA in single-cell RNA-seq with DecontX</article-title><source>Genome Biology</source><volume>21</volume><elocation-id>57</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-020-1950-6</pub-id><pub-id pub-id-type="pmid">32138770</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>AC</given-names></name><name><surname>Kern</surname><given-names>F</given-names></name><name><surname>Losada</surname><given-names>PM</given-names></name><name><surname>Agam</surname><given-names>MR</given-names></name><name><surname>Maat</surname><given-names>CA</given-names></name><name><surname>Schmartz</surname><given-names>GP</given-names></name><name><surname>Fehlmann</surname><given-names>T</given-names></name><name><surname>Stein</surname><given-names>JA</given-names></name><name><surname>Schaum</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>DP</given-names></name><name><surname>Calcuttawala</surname><given-names>K</given-names></name><name><surname>Vest</surname><given-names>RT</given-names></name><name><surname>Berdnik</surname><given-names>D</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Hahn</surname><given-names>O</given-names></name><name><surname>Gate</surname><given-names>D</given-names></name><name><surname>McNerney</surname><given-names>MW</given-names></name><name><surname>Channappa</surname><given-names>D</given-names></name><name><surname>Cobos</surname><given-names>I</given-names></name><name><surname>Ludwig</surname><given-names>N</given-names></name><name><surname>Schulz-Schaeffer</surname><given-names>WJ</given-names></name><name><surname>Keller</surname><given-names>A</given-names></name><name><surname>Wyss-Coray</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Dysregulation of brain and choroid plexus cell types in severe COVID-19</article-title><source>Nature</source><volume>595</volume><fpage>565</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03710-0</pub-id><pub-id pub-id-type="pmid">34153974</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>XX</given-names></name><name><surname>Zheng</surname><given-names>XR</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>ML</given-names></name><name><surname>Mao</surname><given-names>XY</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Vascular Endothelial Growth Factor (VEGF) as a vital target for brain inflammation during the COVID-19 outbreak</article-title><source>ACS Chemical Neuroscience</source><volume>11</volume><fpage>1704</fpage><lpage>1705</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00294</pub-id><pub-id pub-id-type="pmid">32485101</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimatsu</surname><given-names>Y</given-names></name><name><surname>Watabe</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease</article-title><source>Inflammation and Regeneration</source><volume>42</volume><elocation-id>9</elocation-id><pub-id pub-id-type="doi">10.1186/s41232-021-00186-3</pub-id><pub-id pub-id-type="pmid">35130955</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human cross-tissue cell atlases: unprecedented resources towards systematic understanding of physiology and diseases</article-title><source>Signal Transduction and Targeted Therapy</source><volume>7</volume><elocation-id>352</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-022-01201-w</pub-id><pub-id pub-id-type="pmid">36198687</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Linke</surname><given-names>S</given-names></name><name><surname>Dias</surname><given-names>JM</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Gradin</surname><given-names>K</given-names></name><name><surname>Wallis</surname><given-names>TP</given-names></name><name><surname>Hamilton</surname><given-names>BR</given-names></name><name><surname>Gustafsson</surname><given-names>M</given-names></name><name><surname>Ruas</surname><given-names>JL</given-names></name><name><surname>Wilkins</surname><given-names>S</given-names></name><name><surname>Bilton</surname><given-names>RL</given-names></name><name><surname>Brismar</surname><given-names>K</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name><name><surname>Pereira</surname><given-names>T</given-names></name><name><surname>Gorman</surname><given-names>JJ</given-names></name><name><surname>Ericson</surname><given-names>J</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Lendahl</surname><given-names>U</given-names></name><name><surname>Poellinger</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways</article-title><source>PNAS</source><volume>105</volume><fpage>3368</fpage><lpage>3373</lpage><pub-id pub-id-type="doi">10.1073/pnas.0711591105</pub-id><pub-id pub-id-type="pmid">18299578</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><sec sec-type="appendix" id="s8"><title>Details for the COVID Tissue Atlas Consortium</title><sec sec-type="appendix" id="s8-1"><title>Overall Project Direction and Coordination</title><p>Alejandro Granados, Franklin W Huang, Guo N Huang, Michael G Kattah, Tien Peng, Andreas Keller, Angela Oliveira Pisco, Norma Neff, Bruce Wang</p></sec><sec sec-type="appendix" id="s8-2"><title>Writing group</title><p>Alejandro Granados, Hanbing Song, Simon Bucher, Ann T Chen, Angela Oliveira Pisco, Norma Neff, Franklin W. Huang, Bruce Wang</p></sec><sec sec-type="appendix" id="s8-3"><title>Organ Processing and Library Preparation</title><p>Aditi Agrawal, Nancy Allen, Benjamin Hyams Simon Bucher, Deviana Burhan, Angela Detweiler, Shelly Huynh, Nicole Ludwig, Maurizio Morri, Walter Schultz-Schaeffer, Michelle Tan, Hannah NW Weinstein, Rose Yan</p></sec><sec sec-type="appendix" id="s8-4"><title>Sequencing</title><p>Norma Neff, Michelle Tan, Angela Detweiler, Honey Mekonen, Rose (Jia) Yan</p></sec><sec sec-type="appendix" id="s8-5"><title>Data processing</title><p>Aaron McGeever, Angela Oliveira Pisco, Alejandro Granados</p></sec><sec sec-type="appendix" id="s8-6"><title>Cell Type Annotation Expert Group</title><p>Nancy Allen, Xiaoxin Chen, Francisco Galdos, Alejandro Granados, Guo N Huang, Michael G Kattah, Elvira Mennillo, Abhishek Murti, Poorvi Rao, Lulia Rusu, Hanbing Song, Tien Peng, Bruce Wang, Jamie Xie</p></sec><sec sec-type="appendix" id="s8-7"><title>Data Analysis</title><p>Alejandro Granados, Ann T Chen, Hanbing Song, Jonathan Liu, Abhishek Murti</p></sec><sec sec-type="appendix" id="s8-8"><title>Data release and portal</title><p>Alejandro Granados, Sharon S Huang, Alexander Tarashansky, Angela Oliveira Pisco, Kyle Awayan</p></sec></sec></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81090.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Eyras</surname><given-names>Eduardo</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/019wvm592</institution-id><institution>Australian National University</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.05.31.493925" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.05.31.493925"/></front-stub><body><p>This important work provides a valuable data resource to study the systemic effects of severe COVID-19 infection. It further provides compelling evidence for a conserved transcriptional signature in macrophages and endothelial cells in response to COVID-19 and suggests potential molecular interactions between the two cell types. The work will be of broad interest to researchers investigating the physiological impacts of viral infection and their potential treatment.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81090.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Eyras</surname><given-names>Eduardo</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/019wvm592</institution-id><institution>Australian National University</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.05.31.493925">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.05.31.493925v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Single nuclei characterization of pervasive transcriptional signatures across organs in response to COVID19&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Aleksandra Walczak as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Please provide more evidence to support the presence of ABI cells in the data.</p><p>Please clarify the presence and potential role of neuronal cells in the datasets studied, and their fate during infection.</p><p>Please indicate whether the increase of endothelial cells is related to blood vessel formation, e.g. through a cell subtype analysis. A higher resolution study of these subtypes and their potential role will add value to this resource.</p><p>Please describe other variables that might be associated with changes in cell proportions and gene expression, like age and comorbidities.</p><p>Please clarify the potential biases and limitations of this study, and how it compares with other previous similar studies, emphasizing the novel insights and/or complementarity of this study.</p><p>Please clarify the nature of the coordinated response put forward in the manuscript. In particular, whether this is consistent across cell types, or specific to some of them, or not. Any orthogonal validation that could be used to confirm these claims will add further support to the principles put forward in the manuscript</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors performed scRNA-seq of six human organs across 20 autopsies. The data quality and batch effects were well controlled in the analysis. Based on this, the authors identified specific and common changes in each organ after infection with SARS-CoV2. Specifically, the authors observed dysregulation in insulin and HIF signal pathways in the heart and lung. In addition to lung, the authors found significant transcriptional changes in macrophages and endothelial cells in heart and liver. This study provides a valuable data resource to study the systemic effects of severe COVID-19. However, it needs to address the following issues:</p><p>1. The anchor integration alone was not sufficient to indicate the presence of ABIs cells in the data, did the authors observe the expression of ABIs cells markers in the cells they predicted as ABIs in their data?</p><p>2. Considering that the nervous system may be affected by COVID-19 autopsies, did the authors detect neuronal cells in different organs? What happens to them after infection with SARS-CoV2?</p><p>3. The analysis showed a much higher proportion of endothelial cells in the lungs and heart in COVID-19 than in control, were increased blood vessels observed in these organs? Do these extra vessels function normally? If yes, it would be interesting to explore why these organs need so many endothelial cells.</p><p>4. Whether alterations in cell proportions and gene expression in COVID-19 are associated with age or some underlying diseases？</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Expansion of hepatocytes in the liver is very interesting. Hepatocytes play a significant role in both glucose and lipid metabolism. These 2 pathways are tightly regulated by insulin signalling. Since the authors are reporting dysregulation of insulin signalling with potential hepatocytes regeneration caused by COVID-19, this could be further discussed. For example, did changes of insulin signalling lead to dysregulation of lipid metabolism?</p><p>Differential abundance analysis (e.g. Milo) is a better alternative than plotting % of cell types in health vs COVID-19.</p><p>The term COVID-19 has been inconsistently labelled throughout the paper, COVID-19, COVID, Cov19. It'd be great to have the term used consistently throughout the paper to avoid confusion.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81090.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Please provide more evidence to support the presence of ABI cells in the data.</p></disp-quote><p>We thank the reviewer for the advice and agree that it is essential to provide more evidence of ABI cells’ existence in our dataset. Therefore, we computed the top differentially expressed genes of the ABI (transitional AT2) cells from the Habermann et al. dataset and derived an ABI signature gene set. Next, we investigated this signature in the CTA and integrated datasets (CTA + Habermann et al.). Even though no subcluster showed enrichment for the ABI signature, a number of the ABI markers, in particular, those genes expressed in the KRT17+/KrRT5- cells, appeared in our basal population (Figure 2F), suggesting that the ABI population (Kathiriya et al.) was present in the COVID-19 lung. We speculate that trans-differentiation from endogenous AT2s could account for the gain of abnormal basal cells in the alveoli. We revised the manuscript accordingly to reflect this finding. We included a new heatmap to show the expression of the ABI gene signature within the lung epithelial cells from the CTA (Figure 2F).</p><p>Similarly, we derived a signature gene set of the pre-alveolar Type 1 transitional cell state (PATS) population in COVID-19 lungs from the Broad atlas. However, even though these PATS cells bear similarities to the previously described <italic>ABIs/Transitional AT2s/aberrant basaloid</italic> cells from IPF lungs (Habermann et al. and Kathiriya et al.), we did not detect any specific cell cluster in the CTA dataset enriched for the PATS signature. This result suggests that the PATS population is likely patient-specific ( or specific to sequencing technology differences) and, therefore, was not detected in the CTA donors. Accordingly, in the revised manuscript, we modified our PATS analysis description.</p><disp-quote content-type="editor-comment"><p>Please clarify the presence and potential role of neuronal cells in the datasets studied, and their fate during infection.</p></disp-quote><p>We identified a small subset of cells in the hearts of COVID-19 donors expressing high neuronal markers levels. Among the most enriched gene markers in this cluster compared to other cell types in the heart, we found the neuron-specific genes NRX1, NRX3, and XKR4, along with cancer-related genes such as ANK3 (typically enriched in oligodendrocytes) and BCL2 (also found in skeletal myocytes). We also found CDH19 among this cluster's top markers, typically in the brain and heart muscle. Therefore, the cluster comprises a strong signature of neuron-like cells expressing heart-related genes. While interesting, it is challenging to confidently assign an identity to this cluster due to a concern regarding RNA contamination.</p><p>During our decontamination pipeline, we noticed that some of the cells expressing neuronal markers also expressed markers exclusively expressed in other cell types. We were able to fix some of this contamination. Still, we suspected that the expression of neuronal markers correlated with RNA contamination. Therefore, we decided to err on caution and not include the cluster in our downstream analysis. Finally, the Broad atlas also identified a small neuronal population in the heart of COVID-19 autopsies (Delorey, 2021), suggesting that the cluster might represent a real population. However, further investigation and deeper sequencing might be necessary to assess the existence and relevance of such a neuron-like population.</p><disp-quote content-type="editor-comment"><p>Please indicate whether the increase of endothelial cells is related to blood vessel formation, e.g. through a cell subtype analysis. A higher resolution study of these subtypes and their potential role will add value to this resource.</p></disp-quote><p>To address this comment, we separately applied a sub-clustering of the endothelial cell populations from the lung and the heart (Figure 3 – Supplement figures 2 and 3). After unbiased clustering, we used a list of gene markers from recently published human lung and heart endothelial cell single-cell atlases to compare with the expression profiles of different endothelial cell clusters in our data. We identified four sub-clusters of endothelial cells in the lung and 4 in the heart. We found that the overall increase in endothelial cells in both organs is driven primarily by an increased proportion of capillary endothelial cells in COVID-19 samples compared to the controls (Figure 3 – Supplement figures 2 and 3). Consistently, a gene ontology analysis from capillary endothelial cells in the lungs showed angiogenesis significantly upregulated. Therefore, our data indicate that capillary endothelial cells are in COVID-19 infection. We attempted a similar analysis on our liver endothelial cell data, but due to the much smaller cell numbers encountered significant patient-specific batch effects that precluded further analysis (data not shown).</p><p>We included two supplemental figures to investigate the changes in endothelial populations. Our results are preliminary but suggest a pivotal role of capillary endothelial cells.</p><disp-quote content-type="editor-comment"><p>Please describe other variables that might be associated with changes in cell proportions and gene expression, like age and comorbidities.</p></disp-quote><p>We appreciate the comment and are interested in exploring the potential correlations between transcriptional changes and clinical variables (e.g., age, race, comorbidities, etc.). We attempted regression analysis using factors including age, race, disease severity (ICU status), and infection length but couldn’t find a strong signal for correlations with gene expression changes. Unfortunately, we don’t have enough donors for the statistical analysis to be reliable. Notably, previous studies also failed to identify correlations with clinical metadata (Delorey, 2021) due to similar issues of low sample size. While we believe those correlations exist and are crucial to understanding the disease, the current limitation is the number of donors in the dataset. By compiling data across multiple datasets, we anticipate that future studies will be able to explore these questions in more detail.</p><disp-quote content-type="editor-comment"><p>Please clarify the potential biases and limitations of this study, and how it compares with other previous similar studies, emphasizing the novel insights and/or complementarity of this study.</p></disp-quote><p>The main novelty of this study is the collection of multiple organs from the same donors and the cross-organ analysis of transcriptional responses. This feature allowed us to identify a coordinated transcriptional response in macrophages and endothelial cells by analyzing the transcriptional changes in multiple organs, which is often overlooked in other studies. We further explored these changes by identifying potential molecular interactions between these two cell types.</p><p>In line with the CZ Biohub commitment to open science, our data is available for exploration through a web portal and can be easily accessed by the community.</p><p>The main limitations of our study include the number of high-quality cells in the analysis, which is lower than in other studies. We sequenced up to 1 million nuclei for this project, but less than 10% passed our quality control. In addition, we believe a significant cause is the longer time between patient death and organ harvest for our samples, with an average time of 63 hours after death, with a few specimens collected more than 96 hours after death. Since our atlas is composed of single-nuclei data, another limitation is the potential transcriptional effects that we cannot observe due to technological limitations. However, our dataset should be complementary to the current body of knowledge regarding COVID-19, and we expect that future analyses, including multiple datasets, will overcome this limitation.</p><p>A general bias we are aware of is the lack of race and sex diversity in our donors: 17 males vs. three females, and ethnicities Hispanic (n=5), African American (n=2), Asian (n=1), and White (n=12). Therefore, our results and conclusions are limited to the context of our donor population.</p><p>We extended the discussion in the main text to include some of the novelties and limitations of the study.</p><disp-quote content-type="editor-comment"><p>Please clarify the nature of the coordinated response put forward in the manuscript. In particular, whether this is consistent across cell types, or specific to some of them, or not. Any orthogonal validation that could be used to confirm these claims will add further support to the principles put forward in the manuscript</p></disp-quote><p>Orthogonal validation of the coordinated response would strengthen the validity of our results. <italic>The coordinated response is strong with only two cell types -&gt; say that we tried.</italic></p><p>We, therefore, applied our analysis to the COVID-19 dataset from the Broad Institute (Delorey et al., 2021). The Broad’s single-nuclei atlas comprises samples from hearts, livers, and lungs from COVID-19-infected autopsies.</p><p>Our main finding in the CTA is the coordinated transcriptional response in macrophages and endothelial cells across multiple organs, particularly in the heart, liver, and lung. Therefore, the Broad atlas provides an ideal opportunity for independent validation of our results. Here is a summary of the main results:</p><list list-type="order"><list-item><p>By applying the same analysis to the Broad atlas, we identified a coordinated response in macrophages and endothelial cells across the heart, liver, and lung of COVID-19 autopsies.</p></list-item><list-item><p>The list of genes showing a coordinated response in the Broad atlas showed high overlap with the coordinated response found in the CTA (50% overlap in macrophages and 55% overlap in endothelial cells).</p></list-item><list-item><p>Further, we found a strong correlation between the log-fold changes in gene expression for the overlapping set of genes. And we included scatterplots showing these correlations in Figure 5.</p></list-item><list-item><p>We explain in detail the analysis in the text and emphasize the importance of this external validation.</p></list-item></list><p>The additional panels and text strongly support our main finding of a coordinated transcriptional response in macrophages and endothelial cells across multiple organs in response to COVID-19.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The authors performed scRNA-seq of six human organs across 20 autopsies. The data quality and batch effects were well controlled in the analysis. Based on this, the authors identified specific and common changes in each organ after infection with SARS-CoV2. Specifically, the authors observed dysregulation in insulin and HIF signal pathways in the heart and lung. In addition to lung, the authors found significant transcriptional changes in macrophages and endothelial cells in heart and liver. This study provides a valuable data resource to study the systemic effects of severe COVID-19. However, it needs to address the following issues:</p><p>1. The anchor integration alone was not sufficient to indicate the presence of ABIs cells in the data, did the authors observe the expression of ABIs cells markers in the cells they predicted as ABIs in their data?</p></disp-quote><p>See the reply to Essential revisions comment #1 above.</p><disp-quote content-type="editor-comment"><p>2. Considering that the nervous system may be affected by COVID-19 autopsies, did the authors detect neuronal cells in different organs? What happens to them after infection with SARS-CoV2?</p></disp-quote><p>See the reply to Essential revisions comment #2 above.</p><disp-quote content-type="editor-comment"><p>3. The analysis showed a much higher proportion of endothelial cells in the lungs and heart in COVID-19 than in control, were increased blood vessels observed in these organs? Do these extra vessels function normally? If yes, it would be interesting to explore why these organs need so many endothelial cells.</p></disp-quote><p>See the reply to Essential revisions comment #3 above.</p><disp-quote content-type="editor-comment"><p>4. Whether alterations in cell proportions and gene expression in COVID-19 are associated with age or some underlying diseases？</p></disp-quote><p>See the reply to Essential revisions comment #4 above.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Expansion of hepatocytes in the liver is very interesting. Hepatocytes play a significant role in both glucose and lipid metabolism. These 2 pathways are tightly regulated by insulin signalling. Since the authors are reporting dysregulation of insulin signalling with potential hepatocytes regeneration caused by COVID-19, this could be further discussed. For example, did changes of insulin signalling lead to dysregulation of lipid metabolism?</p><p>Differential abundance analysis (e.g. Milo) is a better alternative than plotting % of cell types in health vs COVID-19.</p></disp-quote><p>Thanks, we appreciate the comment, although our limited number of samples prevents us from understanding the changes quantitatively. Integration with other studies in the future will facilitate the investigation of changes in cell populations.</p><disp-quote content-type="editor-comment"><p>The term COVID-19 has been inconsistently labelled throughout the paper, COVID-19, COVID, Cov19. It'd be great to have the term used consistently throughout the paper to avoid confusion.</p></disp-quote><p>Thanks. We reviewed the manuscript and edited it where needed.</p></body></sub-article></article>